Num | GO | Overlap | Size | P Value | Adj. P Value |
1 |
REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT |
376 |
1672 |
2.262e-47 |
1.052e-43 |
2 |
REGULATION OF CELL DIFFERENTIATION |
346 |
1492 |
1.652e-46 |
3.842e-43 |
3 |
CARDIOVASCULAR SYSTEM DEVELOPMENT |
215 |
788 |
1.447e-39 |
1.684e-36 |
4 |
CIRCULATORY SYSTEM DEVELOPMENT |
215 |
788 |
1.447e-39 |
1.684e-36 |
5 |
CELL DEVELOPMENT |
318 |
1426 |
6.819e-39 |
6.346e-36 |
6 |
TISSUE DEVELOPMENT |
327 |
1518 |
7.79e-37 |
6.041e-34 |
7 |
REGULATION OF CELLULAR COMPONENT MOVEMENT |
203 |
771 |
6.028e-35 |
4.007e-32 |
8 |
REGULATION OF CELL DEVELOPMENT |
212 |
836 |
6.295e-34 |
3.661e-31 |
9 |
NEUROGENESIS |
301 |
1402 |
1.651e-33 |
8.534e-31 |
10 |
VASCULATURE DEVELOPMENT |
143 |
469 |
5.45e-32 |
2.536e-29 |
11 |
LOCOMOTION |
250 |
1114 |
8.086e-31 |
3.42e-28 |
12 |
BIOLOGICAL ADHESION |
236 |
1032 |
2.333e-30 |
9.045e-28 |
13 |
REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
330 |
1656 |
2.578e-30 |
9.226e-28 |
14 |
REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS |
234 |
1021 |
2.996e-30 |
9.956e-28 |
15 |
MOVEMENT OF CELL OR SUBCELLULAR COMPONENT |
273 |
1275 |
4.149e-30 |
1.287e-27 |
16 |
BLOOD VESSEL MORPHOGENESIS |
118 |
364 |
3.118e-29 |
9.066e-27 |
17 |
POSITIVE REGULATION OF DEVELOPMENTAL PROCESS |
250 |
1142 |
4.579e-29 |
1.253e-26 |
18 |
INTRACELLULAR SIGNAL TRANSDUCTION |
313 |
1572 |
1.257e-28 |
3.241e-26 |
19 |
CELLULAR RESPONSE TO ENDOGENOUS STIMULUS |
228 |
1008 |
1.324e-28 |
3.241e-26 |
20 |
NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
223 |
983 |
3.633e-28 |
8.452e-26 |
21 |
POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
285 |
1395 |
6.952e-28 |
1.54e-25 |
22 |
RESPONSE TO ENDOGENOUS STIMULUS |
293 |
1450 |
7.503e-28 |
1.587e-25 |
23 |
POSITIVE REGULATION OF RESPONSE TO STIMULUS |
358 |
1929 |
9.489e-27 |
1.92e-24 |
24 |
NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS |
190 |
801 |
1.612e-26 |
3.126e-24 |
25 |
REGULATION OF NEURON DIFFERENTIATION |
148 |
554 |
2.584e-26 |
4.809e-24 |
26 |
POSITIVE REGULATION OF CELL DIFFERENTIATION |
191 |
823 |
2.006e-25 |
3.59e-23 |
27 |
CELLULAR RESPONSE TO ORGANIC SUBSTANCE |
342 |
1848 |
2.841e-25 |
4.896e-23 |
28 |
NEGATIVE REGULATION OF RESPONSE TO STIMULUS |
271 |
1360 |
9.279e-25 |
1.542e-22 |
29 |
CELL MOTILITY |
191 |
835 |
1.273e-24 |
1.974e-22 |
30 |
LOCALIZATION OF CELL |
191 |
835 |
1.273e-24 |
1.974e-22 |
31 |
ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS |
210 |
957 |
1.458e-24 |
2.188e-22 |
32 |
REGULATION OF CELL PROLIFERATION |
290 |
1496 |
1.558e-24 |
2.266e-22 |
33 |
REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
177 |
750 |
1.791e-24 |
2.525e-22 |
34 |
HEART DEVELOPMENT |
127 |
466 |
1.503e-23 |
2.056e-21 |
35 |
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
326 |
1784 |
4.259e-23 |
5.662e-21 |
36 |
ORGAN MORPHOGENESIS |
188 |
841 |
5.182e-23 |
6.697e-21 |
37 |
ANGIOGENESIS |
93 |
293 |
1.519e-22 |
1.911e-20 |
38 |
REGULATION OF PHOSPHORUS METABOLIC PROCESS |
301 |
1618 |
1.597e-22 |
1.955e-20 |
39 |
POSITIVE REGULATION OF CELL COMMUNICATION |
288 |
1532 |
3.06e-22 |
3.651e-20 |
40 |
POSITIVE REGULATION OF GENE EXPRESSION |
316 |
1733 |
3.245e-22 |
3.775e-20 |
41 |
REGULATION OF CELL ADHESION |
152 |
629 |
3.369e-22 |
3.823e-20 |
42 |
MUSCLE STRUCTURE DEVELOPMENT |
118 |
432 |
4.804e-22 |
5.322e-20 |
43 |
SKELETAL SYSTEM DEVELOPMENT |
122 |
455 |
5.237e-22 |
5.667e-20 |
44 |
CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
132 |
513 |
5.724e-22 |
6.053e-20 |
45 |
NEGATIVE REGULATION OF CELL DIFFERENTIATION |
148 |
609 |
6.85e-22 |
7.083e-20 |
46 |
POSITIVE REGULATION OF LOCOMOTION |
115 |
420 |
1.321e-21 |
1.336e-19 |
47 |
NEURON DIFFERENTIATION |
189 |
874 |
2.144e-21 |
2.123e-19 |
48 |
REGULATION OF PROTEIN MODIFICATION PROCESS |
310 |
1710 |
2.23e-21 |
2.162e-19 |
49 |
PROTEIN PHOSPHORYLATION |
197 |
944 |
2.109e-20 |
1.966e-18 |
50 |
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
206 |
1004 |
2.113e-20 |
1.966e-18 |
51 |
NEGATIVE REGULATION OF CELL COMMUNICATION |
233 |
1192 |
3.483e-20 |
3.178e-18 |
52 |
CELLULAR COMPONENT MORPHOGENESIS |
189 |
900 |
6.53e-20 |
5.843e-18 |
53 |
ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY |
156 |
689 |
8.706e-20 |
7.643e-18 |
54 |
CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND |
172 |
799 |
2.522e-19 |
2.173e-17 |
55 |
REGULATION OF CELL DEATH |
270 |
1472 |
2.577e-19 |
2.18e-17 |
56 |
MUSCLE TISSUE DEVELOPMENT |
84 |
275 |
2.635e-19 |
2.19e-17 |
57 |
REGULATION OF NEURON PROJECTION DEVELOPMENT |
108 |
408 |
3.684e-19 |
3.007e-17 |
58 |
POSITIVE REGULATION OF MOLECULAR FUNCTION |
313 |
1791 |
4.425e-19 |
3.55e-17 |
59 |
RESPONSE TO OXYGEN CONTAINING COMPOUND |
256 |
1381 |
6.148e-19 |
4.848e-17 |
60 |
POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS |
271 |
1492 |
8.635e-19 |
6.696e-17 |
61 |
EPITHELIUM DEVELOPMENT |
192 |
945 |
1.415e-18 |
1.078e-16 |
62 |
REGULATION OF CELL PROJECTION ORGANIZATION |
132 |
558 |
1.436e-18 |
1.078e-16 |
63 |
TUBE DEVELOPMENT |
131 |
552 |
1.464e-18 |
1.081e-16 |
64 |
POSITIVE REGULATION OF CELL PROLIFERATION |
172 |
814 |
1.805e-18 |
1.312e-16 |
65 |
NEURON DEVELOPMENT |
152 |
687 |
2.545e-18 |
1.822e-16 |
66 |
POSITIVE REGULATION OF BIOSYNTHETIC PROCESS |
312 |
1805 |
2.689e-18 |
1.896e-16 |
67 |
NEURON PROJECTION MORPHOGENESIS |
105 |
402 |
3.288e-18 |
2.283e-16 |
68 |
POSITIVE REGULATION OF CELL DEVELOPMENT |
116 |
472 |
8.787e-18 |
6.012e-16 |
69 |
RESPONSE TO EXTERNAL STIMULUS |
312 |
1821 |
1.001e-17 |
6.748e-16 |
70 |
NEURON PROJECTION DEVELOPMENT |
127 |
545 |
2.385e-17 |
1.585e-15 |
71 |
EMBRYONIC MORPHOGENESIS |
126 |
539 |
2.45e-17 |
1.606e-15 |
72 |
PHOSPHORYLATION |
229 |
1228 |
2.71e-17 |
1.752e-15 |
73 |
EMBRYO DEVELOPMENT |
180 |
894 |
4.726e-17 |
3.013e-15 |
74 |
IMMUNE SYSTEM PROCESS |
331 |
1984 |
4.873e-17 |
3.064e-15 |
75 |
REGULATION OF SYSTEM PROCESS |
120 |
507 |
5.292e-17 |
3.283e-15 |
76 |
RESPONSE TO WOUNDING |
129 |
563 |
5.609e-17 |
3.434e-15 |
77 |
POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
177 |
876 |
6.133e-17 |
3.706e-15 |
78 |
REGULATION OF CELL MORPHOGENESIS |
127 |
552 |
7.002e-17 |
4.177e-15 |
79 |
POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
200 |
1036 |
8.399e-17 |
4.885e-15 |
80 |
POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
200 |
1036 |
8.399e-17 |
4.885e-15 |
81 |
EXTRACELLULAR STRUCTURE ORGANIZATION |
84 |
304 |
2.248e-16 |
1.291e-14 |
82 |
ACTIN FILAMENT BASED PROCESS |
109 |
450 |
2.645e-16 |
1.501e-14 |
83 |
CELL ACTIVATION |
128 |
568 |
2.983e-16 |
1.672e-14 |
84 |
POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
212 |
1135 |
3.922e-16 |
2.173e-14 |
85 |
RESPONSE TO NITROGEN COMPOUND |
172 |
859 |
4.27e-16 |
2.338e-14 |
86 |
REGULATION OF VASCULATURE DEVELOPMENT |
70 |
233 |
6.754e-16 |
3.654e-14 |
87 |
CELLULAR RESPONSE TO NITROGEN COMPOUND |
117 |
505 |
7.037e-16 |
3.764e-14 |
88 |
RESPONSE TO GROWTH FACTOR |
112 |
475 |
7.981e-16 |
4.22e-14 |
89 |
REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS |
69 |
229 |
9.221e-16 |
4.715e-14 |
90 |
RESPONSE TO HORMONE |
176 |
893 |
9.184e-16 |
4.715e-14 |
91 |
CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION |
94 |
368 |
9.057e-16 |
4.715e-14 |
92 |
REGULATION OF TRANSPORT |
302 |
1804 |
9.542e-16 |
4.826e-14 |
93 |
TAXIS |
110 |
464 |
9.722e-16 |
4.864e-14 |
94 |
POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
213 |
1152 |
1.029e-15 |
5.096e-14 |
95 |
TISSUE MORPHOGENESIS |
121 |
533 |
1.118e-15 |
5.477e-14 |
96 |
CONNECTIVE TISSUE DEVELOPMENT |
62 |
194 |
1.231e-15 |
5.966e-14 |
97 |
NEGATIVE REGULATION OF CELL PROLIFERATION |
138 |
643 |
1.381e-15 |
6.623e-14 |
98 |
RESPONSE TO MECHANICAL STIMULUS |
65 |
210 |
1.47e-15 |
6.979e-14 |
99 |
REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
88 |
337 |
1.838e-15 |
8.641e-14 |
100 |
NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
152 |
740 |
2.578e-15 |
1.2e-13 |
101 |
REGULATION OF ACTIN FILAMENT BASED PROCESS |
83 |
312 |
3.713e-15 |
1.71e-13 |
102 |
PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS |
322 |
1977 |
4.438e-15 |
2.024e-13 |
103 |
REGULATION OF EPITHELIAL CELL PROLIFERATION |
78 |
285 |
4.719e-15 |
2.132e-13 |
104 |
NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
120 |
541 |
8.837e-15 |
3.916e-13 |
105 |
NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
120 |
541 |
8.837e-15 |
3.916e-13 |
106 |
REGULATION OF IMMUNE SYSTEM PROCESS |
244 |
1403 |
1.129e-14 |
4.954e-13 |
107 |
NEGATIVE REGULATION OF CELL DEVELOPMENT |
80 |
303 |
1.836e-14 |
7.985e-13 |
108 |
MUSCLE CELL DIFFERENTIATION |
68 |
237 |
2.189e-14 |
9.431e-13 |
109 |
UROGENITAL SYSTEM DEVELOPMENT |
79 |
299 |
2.568e-14 |
1.096e-12 |
110 |
IMMUNE SYSTEM DEVELOPMENT |
125 |
582 |
2.986e-14 |
1.263e-12 |
111 |
REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
176 |
926 |
3.053e-14 |
1.28e-12 |
112 |
POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
102 |
437 |
3.192e-14 |
1.326e-12 |
113 |
POSITIVE REGULATION OF CATALYTIC ACTIVITY |
257 |
1518 |
5.033e-14 |
2.072e-12 |
114 |
REGULATION OF MAPK CASCADE |
136 |
660 |
6.263e-14 |
2.556e-12 |
115 |
NEGATIVE REGULATION OF GENE EXPRESSION |
253 |
1493 |
7.334e-14 |
2.967e-12 |
116 |
POSITIVE REGULATION OF NEURON DIFFERENTIATION |
79 |
306 |
9.866e-14 |
3.957e-12 |
117 |
CIRCULATORY SYSTEM PROCESS |
89 |
366 |
1.181e-13 |
4.698e-12 |
118 |
SINGLE ORGANISM CELL ADHESION |
104 |
459 |
1.359e-13 |
5.359e-12 |
119 |
REGULATION OF EPITHELIAL CELL MIGRATION |
53 |
166 |
1.491e-13 |
5.832e-12 |
120 |
CELL CELL ADHESION |
127 |
608 |
1.572e-13 |
6.095e-12 |
121 |
CELLULAR RESPONSE TO HORMONE STIMULUS |
118 |
552 |
2.254e-13 |
8.668e-12 |
122 |
WOUND HEALING |
105 |
470 |
2.688e-13 |
1.025e-11 |
123 |
LEUKOCYTE ACTIVATION |
96 |
414 |
2.792e-13 |
1.056e-11 |
124 |
NEGATIVE REGULATION OF PHOSPHORYLATION |
97 |
422 |
3.676e-13 |
1.379e-11 |
125 |
SENSORY ORGAN DEVELOPMENT |
108 |
493 |
4.661e-13 |
1.735e-11 |
126 |
NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
99 |
437 |
5.353e-13 |
1.961e-11 |
127 |
DEVELOPMENTAL GROWTH |
82 |
333 |
5.347e-13 |
1.961e-11 |
128 |
REGULATION OF GTPASE ACTIVITY |
135 |
673 |
6.359e-13 |
2.312e-11 |
129 |
REGULATION OF GROWTH |
129 |
633 |
6.539e-13 |
2.359e-11 |
130 |
RESPONSE TO ABIOTIC STIMULUS |
185 |
1024 |
8.231e-13 |
2.946e-11 |
131 |
REGULATION OF OSSIFICATION |
54 |
178 |
8.972e-13 |
3.187e-11 |
132 |
TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY |
108 |
498 |
9.197e-13 |
3.242e-11 |
133 |
GROWTH |
94 |
410 |
1.001e-12 |
3.501e-11 |
134 |
POSITIVE REGULATION OF CELL DEATH |
124 |
605 |
1.23e-12 |
4.271e-11 |
135 |
RESPONSE TO TRANSFORMING GROWTH FACTOR BETA |
47 |
144 |
1.439e-12 |
4.961e-11 |
136 |
REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
103 |
470 |
1.595e-12 |
5.457e-11 |
137 |
TUBE MORPHOGENESIS |
79 |
323 |
2.069e-12 |
7.029e-11 |
138 |
CENTRAL NERVOUS SYSTEM DEVELOPMENT |
162 |
872 |
2.406e-12 |
8.114e-11 |
139 |
CELL PROJECTION ORGANIZATION |
166 |
902 |
2.838e-12 |
9.5e-11 |
140 |
REGULATION OF KINASE ACTIVITY |
148 |
776 |
2.907e-12 |
9.601e-11 |
141 |
POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT |
63 |
232 |
2.909e-12 |
9.601e-11 |
142 |
CELL FATE COMMITMENT |
62 |
227 |
3.291e-12 |
1.079e-10 |
143 |
NEURON PROJECTION GUIDANCE |
58 |
205 |
3.364e-12 |
1.094e-10 |
144 |
EPITHELIAL CELL DIFFERENTIATION |
106 |
495 |
3.427e-12 |
1.107e-10 |
145 |
POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION |
75 |
303 |
3.998e-12 |
1.283e-10 |
146 |
NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS |
249 |
1517 |
4.061e-12 |
1.294e-10 |
147 |
LEUKOCYTE DIFFERENTIATION |
73 |
292 |
4.627e-12 |
1.465e-10 |
148 |
REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
58 |
207 |
5.222e-12 |
1.642e-10 |
149 |
RESPONSE TO ORGANIC CYCLIC COMPOUND |
167 |
917 |
5.909e-12 |
1.845e-10 |
150 |
REGULATION OF BODY FLUID LEVELS |
107 |
506 |
6.131e-12 |
1.902e-10 |
151 |
LYMPHOCYTE ACTIVATION |
81 |
342 |
6.488e-12 |
1.999e-10 |
152 |
MUSCLE ORGAN DEVELOPMENT |
70 |
277 |
7.419e-12 |
2.271e-10 |
153 |
REGULATION OF MAP KINASE ACTIVITY |
77 |
319 |
7.942e-12 |
2.415e-10 |
154 |
MORPHOGENESIS OF AN EPITHELIUM |
90 |
400 |
9.158e-12 |
2.767e-10 |
155 |
BEHAVIOR |
108 |
516 |
9.485e-12 |
2.847e-10 |
156 |
POSITIVE REGULATION OF CELL ADHESION |
86 |
376 |
1.064e-11 |
3.174e-10 |
157 |
NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
69 |
274 |
1.243e-11 |
3.685e-10 |
158 |
MESENCHYME DEVELOPMENT |
54 |
190 |
1.537e-11 |
4.525e-10 |
159 |
RESPONSE TO OXYGEN LEVELS |
75 |
311 |
1.555e-11 |
4.55e-10 |
160 |
NEGATIVE REGULATION OF CELL DEATH |
159 |
872 |
1.774e-11 |
5.16e-10 |
161 |
POSITIVE REGULATION OF VASCULATURE DEVELOPMENT |
43 |
133 |
1.818e-11 |
5.253e-10 |
162 |
NEGATIVE REGULATION OF NEURON DIFFERENTIATION |
54 |
191 |
1.92e-11 |
5.514e-10 |
163 |
REGULATION OF SMOOTH MUSCLE CELL MIGRATION |
24 |
49 |
2.541e-11 |
7.254e-10 |
164 |
CARDIAC MUSCLE TISSUE DEVELOPMENT |
44 |
140 |
3.081e-11 |
8.742e-10 |
165 |
STRIATED MUSCLE CELL DIFFERENTIATION |
50 |
173 |
4.439e-11 |
1.252e-09 |
166 |
CARTILAGE DEVELOPMENT |
45 |
147 |
4.982e-11 |
1.396e-09 |
167 |
REGULATION OF OSTEOBLAST DIFFERENTIATION |
38 |
112 |
5.342e-11 |
1.488e-09 |
168 |
REGULATION OF HYDROLASE ACTIVITY |
219 |
1327 |
5.603e-11 |
1.552e-09 |
169 |
REGULATION OF ENDOTHELIAL CELL PROLIFERATION |
35 |
98 |
5.964e-11 |
1.642e-09 |
170 |
REGULATION OF ANATOMICAL STRUCTURE SIZE |
99 |
472 |
6.2e-11 |
1.697e-09 |
171 |
POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION |
36 |
103 |
6.499e-11 |
1.768e-09 |
172 |
REGULATION OF HEMOPOIESIS |
74 |
314 |
6.756e-11 |
1.828e-09 |
173 |
TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
136 |
724 |
6.878e-11 |
1.85e-09 |
174 |
EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING |
111 |
554 |
8.158e-11 |
2.181e-09 |
175 |
SINGLE ORGANISM BEHAVIOR |
85 |
384 |
8.405e-11 |
2.235e-09 |
176 |
NEGATIVE REGULATION OF LOCOMOTION |
65 |
263 |
1.153e-10 |
3.048e-09 |
177 |
BONE DEVELOPMENT |
46 |
156 |
1.252e-10 |
3.291e-09 |
178 |
REGULATION OF BLOOD CIRCULATION |
70 |
295 |
1.595e-10 |
4.17e-09 |
179 |
REGULATION OF DEVELOPMENTAL GROWTH |
69 |
289 |
1.614e-10 |
4.195e-09 |
180 |
STEM CELL DIFFERENTIATION |
52 |
190 |
1.668e-10 |
4.311e-09 |
181 |
REGULATION OF RESPONSE TO STRESS |
235 |
1468 |
2.098e-10 |
5.383e-09 |
182 |
REGULATION OF CHEMOTAXIS |
50 |
180 |
2.106e-10 |
5.383e-09 |
183 |
LEUKOCYTE CELL CELL ADHESION |
63 |
255 |
2.257e-10 |
5.738e-09 |
184 |
POSITIVE REGULATION OF MAPK CASCADE |
97 |
470 |
2.452e-10 |
6.2e-09 |
185 |
REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING |
42 |
138 |
2.663e-10 |
6.697e-09 |
186 |
EMBRYONIC ORGAN DEVELOPMENT |
87 |
406 |
2.918e-10 |
7.301e-09 |
187 |
SECRETION BY CELL |
99 |
486 |
3.397e-10 |
8.452e-09 |
188 |
MESENCHYMAL CELL DIFFERENTIATION |
41 |
134 |
3.614e-10 |
8.946e-09 |
189 |
ENDOTHELIUM DEVELOPMENT |
32 |
90 |
4.465e-10 |
1.099e-08 |
190 |
HEART MORPHOGENESIS |
55 |
212 |
4.505e-10 |
1.103e-08 |
191 |
POSITIVE REGULATION OF KINASE ACTIVITY |
98 |
482 |
4.644e-10 |
1.131e-08 |
192 |
REGULATION OF CELL SUBSTRATE ADHESION |
48 |
173 |
5.023e-10 |
1.217e-08 |
193 |
NEGATIVE REGULATION OF GROWTH |
59 |
236 |
5.108e-10 |
1.231e-08 |
194 |
REGULATION OF CELL GROWTH |
84 |
391 |
5.185e-10 |
1.244e-08 |
195 |
SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION |
86 |
404 |
5.224e-10 |
1.247e-08 |
196 |
REGULATION OF CELLULAR COMPONENT BIOGENESIS |
139 |
767 |
5.375e-10 |
1.276e-08 |
197 |
POSITIVE REGULATION OF HYDROLASE ACTIVITY |
158 |
905 |
5.867e-10 |
1.386e-08 |
198 |
REGULATION OF RESPONSE TO WOUNDING |
87 |
413 |
7.183e-10 |
1.688e-08 |
199 |
NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
63 |
262 |
7.365e-10 |
1.722e-08 |
200 |
LYMPHOCYTE DIFFERENTIATION |
54 |
209 |
7.605e-10 |
1.769e-08 |
201 |
REGULATION OF MEMBRANE POTENTIAL |
76 |
343 |
7.968e-10 |
1.844e-08 |
202 |
REGULATION OF HEART CONTRACTION |
56 |
221 |
8.157e-10 |
1.879e-08 |
203 |
REGULATION OF TRANSFERASE ACTIVITY |
163 |
946 |
8.4e-10 |
1.925e-08 |
204 |
REGULATION OF CYTOPLASMIC TRANSPORT |
97 |
481 |
8.986e-10 |
2.05e-08 |
205 |
REGULATION OF METAL ION TRANSPORT |
73 |
325 |
9.093e-10 |
2.064e-08 |
206 |
DEVELOPMENTAL MATURATION |
51 |
193 |
9.6e-10 |
2.168e-08 |
207 |
MUSCLE SYSTEM PROCESS |
66 |
282 |
9.753e-10 |
2.192e-08 |
208 |
CELL PART MORPHOGENESIS |
119 |
633 |
1.049e-09 |
2.346e-08 |
209 |
MUSCLE CELL DEVELOPMENT |
39 |
128 |
1.105e-09 |
2.461e-08 |
210 |
RESPONSE TO PEPTIDE |
85 |
404 |
1.199e-09 |
2.657e-08 |
211 |
LEUKOCYTE MIGRATION |
62 |
259 |
1.213e-09 |
2.674e-08 |
212 |
REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION |
65 |
278 |
1.361e-09 |
2.987e-08 |
213 |
POSITIVE REGULATION OF OSSIFICATION |
30 |
84 |
1.374e-09 |
3.001e-08 |
214 |
REGULATION OF MUSCLE SYSTEM PROCESS |
51 |
195 |
1.416e-09 |
3.08e-08 |
215 |
CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND |
94 |
465 |
1.438e-09 |
3.112e-08 |
216 |
NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS |
181 |
1087 |
1.491e-09 |
3.212e-08 |
217 |
SECRETION |
112 |
588 |
1.509e-09 |
3.235e-08 |
218 |
NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
116 |
616 |
1.542e-09 |
3.292e-08 |
219 |
REGULATION OF CELL CELL ADHESION |
81 |
380 |
1.553e-09 |
3.3e-08 |
220 |
REGULATION OF CELLULAR LOCALIZATION |
206 |
1277 |
1.609e-09 |
3.403e-08 |
221 |
TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
50 |
190 |
1.629e-09 |
3.43e-08 |
222 |
CYTOSKELETON ORGANIZATION |
147 |
838 |
1.72e-09 |
3.606e-08 |
223 |
HEAD DEVELOPMENT |
129 |
709 |
1.775e-09 |
3.703e-08 |
224 |
CELLULAR RESPONSE TO PEPTIDE |
64 |
274 |
1.899e-09 |
3.944e-08 |
225 |
RESPONSE TO PURINE CONTAINING COMPOUND |
44 |
158 |
2.307e-09 |
4.77e-08 |
226 |
CELLULAR RESPONSE TO ACID CHEMICAL |
47 |
175 |
2.437e-09 |
5.017e-08 |
227 |
REGULATION OF INTRACELLULAR TRANSPORT |
116 |
621 |
2.514e-09 |
5.154e-08 |
228 |
CELL SUBSTRATE ADHESION |
45 |
164 |
2.543e-09 |
5.191e-08 |
229 |
NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS |
37 |
121 |
2.625e-09 |
5.333e-08 |
230 |
REGULATION OF CELL ACTIVATION |
96 |
484 |
2.699e-09 |
5.46e-08 |
231 |
RESPONSE TO LIPID |
153 |
888 |
2.851e-09 |
5.742e-08 |
232 |
CARDIOCYTE DIFFERENTIATION |
32 |
96 |
2.873e-09 |
5.763e-08 |
233 |
POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION |
26 |
68 |
3.18e-09 |
6.351e-08 |
234 |
POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION |
43 |
154 |
3.198e-09 |
6.36e-08 |
235 |
SECOND MESSENGER MEDIATED SIGNALING |
44 |
160 |
3.534e-09 |
6.998e-08 |
236 |
POSITIVE REGULATION OF TRANSPORT |
159 |
936 |
3.839e-09 |
7.568e-08 |
237 |
POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION |
24 |
60 |
4.415e-09 |
8.668e-08 |
238 |
REGULATION OF ENDOTHELIAL CELL MIGRATION |
35 |
114 |
6.231e-09 |
1.214e-07 |
239 |
REGULATION OF HOMOTYPIC CELL CELL ADHESION |
68 |
307 |
6.233e-09 |
1.214e-07 |
240 |
MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL |
11 |
14 |
6.262e-09 |
1.214e-07 |
241 |
SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION |
75 |
352 |
6.354e-09 |
1.227e-07 |
242 |
REGULATION OF BINDING |
64 |
283 |
7.38e-09 |
1.419e-07 |
243 |
NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION |
35 |
115 |
8.033e-09 |
1.538e-07 |
244 |
FORMATION OF PRIMARY GERM LAYER |
34 |
110 |
8.438e-09 |
1.606e-07 |
245 |
REGULATION OF HOMEOSTATIC PROCESS |
89 |
447 |
8.458e-09 |
1.606e-07 |
246 |
NEGATIVE REGULATION OF CELL GROWTH |
45 |
170 |
8.625e-09 |
1.631e-07 |
247 |
REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION |
32 |
100 |
8.955e-09 |
1.687e-07 |
248 |
POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION |
16 |
30 |
1.116e-08 |
2.094e-07 |
249 |
REGULATION OF CELLULAR COMPONENT SIZE |
72 |
337 |
1.128e-08 |
2.108e-07 |
250 |
SKELETAL SYSTEM MORPHOGENESIS |
50 |
201 |
1.248e-08 |
2.323e-07 |
251 |
ENDOTHELIAL CELL DIFFERENTIATION |
26 |
72 |
1.301e-08 |
2.411e-07 |
252 |
EYE DEVELOPMENT |
70 |
326 |
1.45e-08 |
2.677e-07 |
253 |
REGULATION OF CATION TRANSMEMBRANE TRANSPORT |
51 |
208 |
1.501e-08 |
2.76e-07 |
254 |
MULTICELLULAR ORGANISMAL SIGNALING |
36 |
123 |
1.557e-08 |
2.841e-07 |
255 |
T CELL DIFFERENTIATION |
36 |
123 |
1.557e-08 |
2.841e-07 |
256 |
CELL JUNCTION ORGANIZATION |
47 |
185 |
1.667e-08 |
3.03e-07 |
257 |
POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS |
147 |
867 |
1.728e-08 |
3.129e-07 |
258 |
INOSITOL LIPID MEDIATED SIGNALING |
36 |
124 |
1.968e-08 |
3.549e-07 |
259 |
KIDNEY EPITHELIUM DEVELOPMENT |
36 |
125 |
2.478e-08 |
4.452e-07 |
260 |
CELLULAR RESPONSE TO LIPID |
89 |
457 |
2.52e-08 |
4.51e-07 |
261 |
HEMOSTASIS |
67 |
311 |
2.566e-08 |
4.575e-07 |
262 |
REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY |
31 |
99 |
2.698e-08 |
4.773e-07 |
263 |
REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS |
31 |
99 |
2.698e-08 |
4.773e-07 |
264 |
AMEBOIDAL TYPE CELL MIGRATION |
41 |
154 |
3.268e-08 |
5.759e-07 |
265 |
REGULATION OF ION TRANSPORT |
108 |
592 |
3.295e-08 |
5.786e-07 |
266 |
NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS |
76 |
372 |
3.355e-08 |
5.868e-07 |
267 |
OSSIFICATION |
57 |
251 |
4.128e-08 |
7.193e-07 |
268 |
POSITIVE REGULATION OF TRANSFERASE ACTIVITY |
111 |
616 |
4.189e-08 |
7.273e-07 |
269 |
CELL DEATH |
163 |
1001 |
4.834e-08 |
8.337e-07 |
270 |
REGULATION OF CALCIUM ION TRANSPORT |
50 |
209 |
4.838e-08 |
8.337e-07 |
271 |
REGULATION OF HEART RATE |
28 |
86 |
4.918e-08 |
8.444e-07 |
272 |
POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION |
24 |
67 |
5.6e-08 |
9.579e-07 |
273 |
EPITHELIAL CELL DEVELOPMENT |
46 |
186 |
5.687e-08 |
9.693e-07 |
274 |
NEGATIVE REGULATION OF TRANSPORT |
88 |
458 |
5.74e-08 |
9.748e-07 |
275 |
NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
31 |
102 |
5.852e-08 |
9.902e-07 |
276 |
NEGATIVE REGULATION OF CELL ADHESION |
52 |
223 |
6.453e-08 |
1.088e-06 |
277 |
REGULATION OF STEM CELL DIFFERENTIATION |
33 |
113 |
6.475e-08 |
1.088e-06 |
278 |
LUNG ALVEOLUS DEVELOPMENT |
18 |
41 |
6.796e-08 |
1.137e-06 |
279 |
CELL CELL SIGNALING |
131 |
767 |
6.874e-08 |
1.146e-06 |
280 |
CARDIAC MUSCLE CELL ACTION POTENTIAL |
17 |
37 |
6.896e-08 |
1.146e-06 |
281 |
CELL MATRIX ADHESION |
34 |
119 |
7.445e-08 |
1.233e-06 |
282 |
REGULATED EXOCYTOSIS |
52 |
224 |
7.532e-08 |
1.243e-06 |
283 |
REGULATION OF CELL JUNCTION ASSEMBLY |
24 |
68 |
7.77e-08 |
1.273e-06 |
284 |
ORGAN GROWTH |
24 |
68 |
7.77e-08 |
1.273e-06 |
285 |
ACTIN FILAMENT BASED MOVEMENT |
29 |
93 |
8.319e-08 |
1.353e-06 |
286 |
MULTICELLULAR ORGANISM METABOLIC PROCESS |
29 |
93 |
8.319e-08 |
1.353e-06 |
287 |
SKELETAL MUSCLE ORGAN DEVELOPMENT |
37 |
137 |
1.009e-07 |
1.636e-06 |
288 |
RESPONSE TO ALCOHOL |
73 |
362 |
1.076e-07 |
1.739e-06 |
289 |
CARDIAC MUSCLE CELL DIFFERENTIATION |
25 |
74 |
1.124e-07 |
1.809e-06 |
290 |
GASTRULATION |
40 |
155 |
1.202e-07 |
1.929e-06 |
291 |
NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION |
38 |
144 |
1.319e-07 |
2.109e-06 |
292 |
TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY |
29 |
95 |
1.394e-07 |
2.222e-06 |
293 |
EMBRYONIC ORGAN MORPHOGENESIS |
60 |
279 |
1.444e-07 |
2.293e-06 |
294 |
NEGATIVE REGULATION OF RESPONSE TO WOUNDING |
40 |
156 |
1.45e-07 |
2.295e-06 |
295 |
POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
41 |
162 |
1.497e-07 |
2.362e-06 |
296 |
RESPONSE TO ORGANOPHOSPHORUS |
37 |
139 |
1.511e-07 |
2.376e-06 |
297 |
REGULATION OF AXONOGENESIS |
42 |
168 |
1.533e-07 |
2.401e-06 |
298 |
NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
33 |
117 |
1.611e-07 |
2.515e-06 |
299 |
HOMEOSTATIC PROCESS |
204 |
1337 |
1.643e-07 |
2.557e-06 |
300 |
RESPONSE TO STEROID HORMONE |
92 |
497 |
1.737e-07 |
2.693e-06 |
301 |
NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
118 |
684 |
1.807e-07 |
2.794e-06 |
302 |
APPENDAGE DEVELOPMENT |
42 |
169 |
1.829e-07 |
2.808e-06 |
303 |
LIMB DEVELOPMENT |
42 |
169 |
1.829e-07 |
2.808e-06 |
304 |
CELL JUNCTION ASSEMBLY |
35 |
129 |
1.959e-07 |
2.998e-06 |
305 |
MODULATION OF SYNAPTIC TRANSMISSION |
63 |
301 |
1.996e-07 |
3.046e-06 |
306 |
POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
62 |
296 |
2.42e-07 |
3.679e-06 |
307 |
MUCOPOLYSACCHARIDE METABOLIC PROCESS |
31 |
108 |
2.463e-07 |
3.734e-06 |
308 |
REGULATION OF LEUKOCYTE DIFFERENTIATION |
52 |
232 |
2.477e-07 |
3.742e-06 |
309 |
CHEMICAL HOMEOSTASIS |
143 |
874 |
2.488e-07 |
3.745e-06 |
310 |
REGULATION OF ION HOMEOSTASIS |
47 |
201 |
2.495e-07 |
3.745e-06 |
311 |
REGULATION OF MYELOID CELL DIFFERENTIATION |
44 |
183 |
2.595e-07 |
3.882e-06 |
312 |
CARDIAC CONDUCTION |
26 |
82 |
2.653e-07 |
3.956e-06 |
313 |
ACTOMYOSIN STRUCTURE ORGANIZATION |
25 |
77 |
2.691e-07 |
4.001e-06 |
314 |
FOREBRAIN DEVELOPMENT |
71 |
357 |
2.797e-07 |
4.144e-06 |
315 |
DIGESTIVE SYSTEM DEVELOPMENT |
38 |
148 |
2.836e-07 |
4.19e-06 |
316 |
AMINOGLYCAN METABOLIC PROCESS |
41 |
166 |
3.047e-07 |
4.486e-06 |
317 |
CYTOKINE PRODUCTION |
33 |
120 |
3.081e-07 |
4.509e-06 |
318 |
REGULATION OF DENDRITE DEVELOPMENT |
33 |
120 |
3.081e-07 |
4.509e-06 |
319 |
NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
34 |
126 |
3.353e-07 |
4.89e-06 |
320 |
PLASMA MEMBRANE ORGANIZATION |
47 |
203 |
3.401e-07 |
4.945e-06 |
321 |
PROTEOGLYCAN METABOLIC PROCESS |
26 |
83 |
3.468e-07 |
5.027e-06 |
322 |
LIPID PHOSPHORYLATION |
29 |
99 |
3.713e-07 |
5.365e-06 |
323 |
REGULATION OF CYTOKINE PRODUCTION |
100 |
563 |
3.954e-07 |
5.695e-06 |
324 |
REGULATION OF TRANSPORTER ACTIVITY |
46 |
198 |
4.066e-07 |
5.839e-06 |
325 |
PEPTIDYL TYROSINE MODIFICATION |
44 |
186 |
4.224e-07 |
6.048e-06 |
326 |
MULTICELLULAR ORGANISMAL MACROMOLECULE METABOLIC PROCESS |
25 |
79 |
4.671e-07 |
6.647e-06 |
327 |
BONE MORPHOGENESIS |
25 |
79 |
4.671e-07 |
6.647e-06 |
328 |
POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
60 |
289 |
5.156e-07 |
7.315e-06 |
329 |
REGULATION OF CHONDROCYTE DIFFERENTIATION |
18 |
46 |
5.565e-07 |
7.87e-06 |
330 |
CELLULAR RESPONSE TO INSULIN STIMULUS |
37 |
146 |
5.74e-07 |
8.093e-06 |
331 |
HEART PROCESS |
26 |
85 |
5.831e-07 |
8.197e-06 |
332 |
COGNITION |
54 |
251 |
5.883e-07 |
8.221e-06 |
333 |
POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION |
21 |
60 |
5.868e-07 |
8.221e-06 |
334 |
NEGATIVE REGULATION OF CELL ACTIVATION |
39 |
158 |
5.966e-07 |
8.312e-06 |
335 |
REGULATION OF TRANSMEMBRANE TRANSPORT |
80 |
426 |
6.013e-07 |
8.351e-06 |
336 |
NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT |
25 |
80 |
6.1e-07 |
8.448e-06 |
337 |
ARTERY DEVELOPMENT |
24 |
75 |
6.269e-07 |
8.63e-06 |
338 |
NEURAL CREST CELL DIFFERENTIATION |
24 |
75 |
6.269e-07 |
8.63e-06 |
339 |
SENSORY ORGAN MORPHOGENESIS |
52 |
239 |
6.577e-07 |
9.027e-06 |
340 |
EAR DEVELOPMENT |
45 |
195 |
6.608e-07 |
9.043e-06 |
341 |
PLATELET DEGRANULATION |
30 |
107 |
6.669e-07 |
9.1e-06 |
342 |
MYELOID CELL DIFFERENTIATION |
44 |
189 |
6.775e-07 |
9.218e-06 |
343 |
MUSCLE CONTRACTION |
51 |
233 |
6.93e-07 |
9.401e-06 |
344 |
CELL PROLIFERATION |
114 |
672 |
6.96e-07 |
9.415e-06 |
345 |
REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY |
38 |
153 |
7.013e-07 |
9.459e-06 |
346 |
PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
15 |
34 |
7.853e-07 |
1.053e-05 |
347 |
CAMP METABOLIC PROCESS |
15 |
34 |
7.853e-07 |
1.053e-05 |
348 |
REPRODUCTIVE SYSTEM DEVELOPMENT |
77 |
408 |
7.964e-07 |
1.065e-05 |
349 |
MEMBRANE DEPOLARIZATION |
21 |
61 |
8.04e-07 |
1.072e-05 |
350 |
REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION |
43 |
184 |
8.091e-07 |
1.076e-05 |
351 |
REGULATION OF CELL SIZE |
41 |
172 |
8.346e-07 |
1.106e-05 |
352 |
TELENCEPHALON DEVELOPMENT |
50 |
228 |
8.364e-07 |
1.106e-05 |
353 |
CELL MATURATION |
34 |
131 |
8.995e-07 |
1.186e-05 |
354 |
NEGATIVE REGULATION OF MOLECULAR FUNCTION |
167 |
1079 |
9.571e-07 |
1.258e-05 |
355 |
CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS |
17 |
43 |
9.655e-07 |
1.265e-05 |
356 |
POSITIVE REGULATION OF CHEMOTAXIS |
32 |
120 |
9.785e-07 |
1.279e-05 |
357 |
REGULATION OF ORGAN MORPHOGENESIS |
52 |
242 |
9.822e-07 |
1.28e-05 |
358 |
REGULATION OF CYTOSKELETON ORGANIZATION |
90 |
502 |
9.945e-07 |
1.293e-05 |
359 |
REGULATION OF WOUND HEALING |
33 |
126 |
1.038e-06 |
1.346e-05 |
360 |
POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING |
21 |
62 |
1.092e-06 |
1.412e-05 |
361 |
NEPHRON DEVELOPMENT |
31 |
115 |
1.116e-06 |
1.438e-05 |
362 |
CARDIAC CHAMBER DEVELOPMENT |
36 |
144 |
1.152e-06 |
1.477e-05 |
363 |
RESPONSE TO CAMP |
29 |
104 |
1.152e-06 |
1.477e-05 |
364 |
RESPONSE TO INSULIN |
46 |
205 |
1.156e-06 |
1.477e-05 |
365 |
REGULATION OF CATABOLIC PROCESS |
121 |
731 |
1.165e-06 |
1.485e-05 |
366 |
CELL CHEMOTAXIS |
39 |
162 |
1.175e-06 |
1.494e-05 |
367 |
NEGATIVE REGULATION OF KINASE ACTIVITY |
53 |
250 |
1.199e-06 |
1.52e-05 |
368 |
EXOCYTOSIS |
62 |
310 |
1.28e-06 |
1.618e-05 |
369 |
POSITIVE REGULATION OF CELL SUBSTRATE ADHESION |
28 |
99 |
1.284e-06 |
1.619e-05 |
370 |
CELLULAR RESPONSE TO EXTERNAL STIMULUS |
55 |
264 |
1.352e-06 |
1.7e-05 |
371 |
SYNAPSE ORGANIZATION |
36 |
145 |
1.375e-06 |
1.724e-05 |
372 |
ACTION POTENTIAL |
27 |
94 |
1.419e-06 |
1.774e-05 |
373 |
IN UTERO EMBRYONIC DEVELOPMENT |
62 |
311 |
1.432e-06 |
1.787e-05 |
374 |
REGULATION OF CARTILAGE DEVELOPMENT |
21 |
63 |
1.472e-06 |
1.822e-05 |
375 |
REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION |
47 |
213 |
1.468e-06 |
1.822e-05 |
376 |
REGULATION OF MUSCLE ADAPTATION |
21 |
63 |
1.472e-06 |
1.822e-05 |
377 |
POSITIVE REGULATION OF MAP KINASE ACTIVITY |
46 |
207 |
1.538e-06 |
1.898e-05 |
378 |
RESPONSE TO INORGANIC SUBSTANCE |
86 |
479 |
1.62e-06 |
1.995e-05 |
379 |
REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS |
37 |
152 |
1.647e-06 |
2.022e-05 |
380 |
SYSTEM PROCESS |
254 |
1785 |
1.764e-06 |
2.161e-05 |
381 |
RESPONSE TO DRUG |
79 |
431 |
1.885e-06 |
2.297e-05 |
382 |
NEGATIVE REGULATION OF NEURON DEATH |
40 |
171 |
1.882e-06 |
2.297e-05 |
383 |
REGULATION OF EXTENT OF CELL GROWTH |
28 |
101 |
1.987e-06 |
2.414e-05 |
384 |
RESPIRATORY SYSTEM DEVELOPMENT |
44 |
197 |
2.231e-06 |
2.703e-05 |
385 |
CELL SUBSTRATE JUNCTION ASSEMBLY |
16 |
41 |
2.467e-06 |
2.982e-05 |
386 |
CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT |
22 |
70 |
2.556e-06 |
3.081e-05 |
387 |
CHONDROCYTE DIFFERENTIATION |
20 |
60 |
2.605e-06 |
3.132e-05 |
388 |
MORPHOGENESIS OF A BRANCHING STRUCTURE |
39 |
167 |
2.627e-06 |
3.151e-05 |
389 |
PROTEIN AUTOPHOSPHORYLATION |
43 |
192 |
2.685e-06 |
3.212e-05 |
390 |
RAS PROTEIN SIGNAL TRANSDUCTION |
35 |
143 |
2.722e-06 |
3.248e-05 |
391 |
CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION |
15 |
37 |
2.888e-06 |
3.437e-05 |
392 |
POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING |
24 |
81 |
2.942e-06 |
3.492e-05 |
393 |
PROTEIN LOCALIZATION |
255 |
1805 |
2.954e-06 |
3.497e-05 |
394 |
REGULATION OF PROTEIN BINDING |
39 |
168 |
3.069e-06 |
3.624e-05 |
395 |
RHYTHMIC PROCESS |
59 |
298 |
3.204e-06 |
3.774e-05 |
396 |
ARTERY MORPHOGENESIS |
18 |
51 |
3.237e-06 |
3.803e-05 |
397 |
REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY |
49 |
232 |
3.333e-06 |
3.907e-05 |
398 |
MEMBRANE ASSEMBLY |
12 |
25 |
3.393e-06 |
3.957e-05 |
399 |
CHONDROITIN SULFATE BIOSYNTHETIC PROCESS |
12 |
25 |
3.393e-06 |
3.957e-05 |
400 |
NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS |
21 |
66 |
3.445e-06 |
3.978e-05 |
401 |
RESPONSE TO ACID CHEMICAL |
62 |
319 |
3.433e-06 |
3.978e-05 |
402 |
NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY |
21 |
66 |
3.445e-06 |
3.978e-05 |
403 |
REGULATION OF CARDIAC MUSCLE CONTRACTION |
21 |
66 |
3.445e-06 |
3.978e-05 |
404 |
CARDIAC MUSCLE CELL CONTRACTION |
13 |
29 |
3.457e-06 |
3.982e-05 |
405 |
GLIOGENESIS |
40 |
175 |
3.474e-06 |
3.991e-05 |
406 |
REGULATION OF NEURON DEATH |
52 |
252 |
3.482e-06 |
3.991e-05 |
407 |
CARDIAC CHAMBER MORPHOGENESIS |
28 |
104 |
3.724e-06 |
4.258e-05 |
408 |
NEGATIVE REGULATION OF MAPK CASCADE |
35 |
145 |
3.816e-06 |
4.352e-05 |
409 |
NEURON MIGRATION |
29 |
110 |
3.975e-06 |
4.522e-05 |
410 |
REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT |
30 |
116 |
4.176e-06 |
4.74e-05 |
411 |
EMBRYONIC SKELETAL SYSTEM DEVELOPMENT |
31 |
122 |
4.329e-06 |
4.889e-05 |
412 |
REGULATION OF EPITHELIAL CELL DIFFERENTIATION |
31 |
122 |
4.329e-06 |
4.889e-05 |
413 |
REGULATION OF PROTEIN LOCALIZATION |
147 |
950 |
4.416e-06 |
4.975e-05 |
414 |
REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION |
21 |
67 |
4.509e-06 |
5.068e-05 |
415 |
CARDIAC VENTRICLE MORPHOGENESIS |
20 |
62 |
4.622e-06 |
5.183e-05 |
416 |
RESPONSE TO FLUID SHEAR STRESS |
14 |
34 |
4.974e-06 |
5.563e-05 |
417 |
REGULATION OF JNK CASCADE |
37 |
159 |
5.122e-06 |
5.716e-05 |
418 |
CELL FATE DETERMINATION |
16 |
43 |
5.139e-06 |
5.72e-05 |
419 |
CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION |
11 |
22 |
5.301e-06 |
5.887e-05 |
420 |
REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
43 |
197 |
5.412e-06 |
5.996e-05 |
421 |
REGULATION OF FAT CELL DIFFERENTIATION |
28 |
106 |
5.562e-06 |
6.133e-05 |
422 |
FAT CELL DIFFERENTIATION |
28 |
106 |
5.562e-06 |
6.133e-05 |
423 |
MYOFIBRIL ASSEMBLY |
17 |
48 |
5.728e-06 |
6.301e-05 |
424 |
NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH |
24 |
84 |
5.936e-06 |
6.514e-05 |
425 |
PROTEOGLYCAN BIOSYNTHETIC PROCESS |
19 |
58 |
6.169e-06 |
6.753e-05 |
426 |
MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL |
15 |
39 |
6.283e-06 |
6.847e-05 |
427 |
NEGATIVE CHEMOTAXIS |
15 |
39 |
6.283e-06 |
6.847e-05 |
428 |
GLAND DEVELOPMENT |
72 |
395 |
6.488e-06 |
7.053e-05 |
429 |
AMINOGLYCAN BIOSYNTHETIC PROCESS |
28 |
107 |
6.764e-06 |
7.336e-05 |
430 |
IMMUNE RESPONSE |
165 |
1100 |
7.311e-06 |
7.911e-05 |
431 |
LEARNING |
32 |
131 |
7.482e-06 |
8.078e-05 |
432 |
GLOMERULUS DEVELOPMENT |
17 |
49 |
7.891e-06 |
8.499e-05 |
433 |
POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION |
10 |
19 |
7.979e-06 |
8.574e-05 |
434 |
REGULATION OF SECRETION |
113 |
699 |
8.052e-06 |
8.632e-05 |
435 |
MULTI MULTICELLULAR ORGANISM PROCESS |
45 |
213 |
8.163e-06 |
8.731e-05 |
436 |
CELLULAR RESPONSE TO MECHANICAL STIMULUS |
23 |
80 |
8.225e-06 |
8.777e-05 |
437 |
POSITIVE REGULATION OF DEVELOPMENTAL GROWTH |
36 |
156 |
8.342e-06 |
8.883e-05 |
438 |
ENDODERMAL CELL DIFFERENTIATION |
15 |
40 |
9.05e-06 |
9.614e-05 |
439 |
REGULATION OF MUSCLE TISSUE DEVELOPMENT |
27 |
103 |
9.474e-06 |
0.0001004 |
440 |
PROTEIN LOCALIZATION TO CELL PERIPHERY |
35 |
151 |
9.988e-06 |
0.0001056 |
441 |
ENDOCHONDRAL BONE MORPHOGENESIS |
16 |
45 |
1.015e-05 |
0.0001071 |
442 |
REGULATION OF PROTEIN KINASE B SIGNALING |
30 |
121 |
1.04e-05 |
0.0001095 |
443 |
CELLULAR RESPONSE TO CAMP |
17 |
50 |
1.076e-05 |
0.0001126 |
444 |
REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION |
19 |
60 |
1.076e-05 |
0.0001126 |
445 |
ENDODERM FORMATION |
17 |
50 |
1.076e-05 |
0.0001126 |
446 |
REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL |
18 |
55 |
1.093e-05 |
0.0001139 |
447 |
REGULATION OF PROTEIN IMPORT |
40 |
183 |
1.094e-05 |
0.0001139 |
448 |
POSITIVE REGULATION OF AXON EXTENSION |
14 |
36 |
1.1e-05 |
0.0001143 |
449 |
RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE |
9 |
16 |
1.133e-05 |
0.0001174 |
450 |
REGULATION OF CALCIUM MEDIATED SIGNALING |
22 |
76 |
1.139e-05 |
0.0001177 |
451 |
DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS |
27 |
104 |
1.149e-05 |
0.0001185 |
452 |
POSITIVE REGULATION OF CATABOLIC PROCESS |
71 |
395 |
1.227e-05 |
0.0001264 |
453 |
INTEGRIN MEDIATED SIGNALING PATHWAY |
23 |
82 |
1.289e-05 |
0.0001324 |
454 |
NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION |
13 |
32 |
1.294e-05 |
0.0001327 |
455 |
PALLIUM DEVELOPMENT |
35 |
153 |
1.355e-05 |
0.0001382 |
456 |
RESPONSE TO REACTIVE OXYGEN SPECIES |
41 |
191 |
1.355e-05 |
0.0001382 |
457 |
REGULATION OF MUSCLE CONTRACTION |
34 |
147 |
1.395e-05 |
0.000142 |
458 |
PATTERN SPECIFICATION PROCESS |
74 |
418 |
1.4e-05 |
0.0001423 |
459 |
ESTABLISHMENT OF CELL POLARITY |
24 |
88 |
1.418e-05 |
0.0001438 |
460 |
COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION |
28 |
111 |
1.432e-05 |
0.0001446 |
461 |
REGULATION OF BMP SIGNALING PATHWAY |
22 |
77 |
1.433e-05 |
0.0001446 |
462 |
NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS |
32 |
135 |
1.453e-05 |
0.0001457 |
463 |
ADULT BEHAVIOR |
32 |
135 |
1.453e-05 |
0.0001457 |
464 |
CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION |
37 |
166 |
1.453e-05 |
0.0001457 |
465 |
RESPONSE TO BMP |
25 |
94 |
1.526e-05 |
0.0001524 |
466 |
CELLULAR RESPONSE TO BMP STIMULUS |
25 |
94 |
1.526e-05 |
0.0001524 |
467 |
REGULATION OF NEURON APOPTOTIC PROCESS |
41 |
192 |
1.545e-05 |
0.000154 |
468 |
REGULATION OF MUSCLE HYPERTROPHY |
14 |
37 |
1.594e-05 |
0.0001585 |
469 |
REGENERATION |
36 |
161 |
1.751e-05 |
0.0001737 |
470 |
REGULATION OF INFLAMMATORY RESPONSE |
56 |
294 |
1.842e-05 |
0.0001823 |
471 |
ION HOMEOSTASIS |
95 |
576 |
1.879e-05 |
0.0001856 |
472 |
CYCLIC NUCLEOTIDE METABOLIC PROCESS |
18 |
57 |
1.905e-05 |
0.0001878 |
473 |
NEURON RECOGNITION |
13 |
33 |
1.924e-05 |
0.0001893 |
474 |
VESICLE MEDIATED TRANSPORT |
180 |
1239 |
1.937e-05 |
0.0001898 |
475 |
REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT |
45 |
220 |
1.938e-05 |
0.0001898 |
476 |
NEGATIVE REGULATION OF MAP KINASE ACTIVITY |
21 |
73 |
1.988e-05 |
0.0001939 |
477 |
LOCOMOTORY BEHAVIOR |
39 |
181 |
1.985e-05 |
0.0001939 |
478 |
RESPONSE TO CYTOKINE |
113 |
714 |
2.112e-05 |
0.0002056 |
479 |
CALCIUM MEDIATED SIGNALING |
24 |
90 |
2.138e-05 |
0.0002068 |
480 |
REGULATION OF CELL MATRIX ADHESION |
24 |
90 |
2.138e-05 |
0.0002068 |
481 |
MESONEPHROS DEVELOPMENT |
24 |
90 |
2.138e-05 |
0.0002068 |
482 |
NEGATIVE REGULATION OF PLATELET ACTIVATION |
9 |
17 |
2.175e-05 |
0.00021 |
483 |
RESPONSE TO OXIDATIVE STRESS |
64 |
352 |
2.244e-05 |
0.0002161 |
484 |
COLLAGEN FIBRIL ORGANIZATION |
14 |
38 |
2.273e-05 |
0.0002186 |
485 |
MAINTENANCE OF CELL NUMBER |
31 |
132 |
2.386e-05 |
0.0002289 |
486 |
OSTEOBLAST DIFFERENTIATION |
30 |
126 |
2.423e-05 |
0.000232 |
487 |
PALATE DEVELOPMENT |
23 |
85 |
2.441e-05 |
0.0002333 |
488 |
CHONDROCYTE DEVELOPMENT |
10 |
21 |
2.483e-05 |
0.0002368 |
489 |
ACTIN MEDIATED CELL CONTRACTION |
21 |
74 |
2.494e-05 |
0.0002374 |
490 |
REGULATION OF PROTEIN SECRETION |
69 |
389 |
2.526e-05 |
0.0002398 |
491 |
NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION |
17 |
53 |
2.57e-05 |
0.0002436 |
492 |
POSITIVE REGULATION OF ION TRANSPORT |
47 |
236 |
2.633e-05 |
0.000249 |
493 |
ADHERENS JUNCTION ASSEMBLY |
13 |
34 |
2.808e-05 |
0.0002645 |
494 |
HEART VALVE DEVELOPMENT |
13 |
34 |
2.808e-05 |
0.0002645 |
495 |
REGULATION OF CELLULAR PROTEIN LOCALIZATION |
91 |
552 |
2.846e-05 |
0.0002675 |
496 |
CELLULAR RESPONSE TO OXIDATIVE STRESS |
39 |
184 |
2.942e-05 |
0.0002759 |
497 |
INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
8 |
14 |
3.074e-05 |
0.0002877 |
498 |
REGULATION OF DEFENSE RESPONSE |
118 |
759 |
3.142e-05 |
0.0002936 |
499 |
REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL |
24 |
92 |
3.171e-05 |
0.0002956 |
500 |
REGULATION OF AXON GUIDANCE |
14 |
39 |
3.195e-05 |
0.0002973 |
501 |
VASCULOGENESIS |
18 |
59 |
3.217e-05 |
0.0002988 |
502 |
ACTIVATION OF PROTEIN KINASE ACTIVITY |
53 |
279 |
3.286e-05 |
0.0003046 |
503 |
MEMBRANE BIOGENESIS |
12 |
30 |
3.361e-05 |
0.0003085 |
504 |
CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS |
12 |
30 |
3.361e-05 |
0.0003085 |
505 |
NEGATIVE REGULATION OF HEMOPOIESIS |
30 |
128 |
3.34e-05 |
0.0003085 |
506 |
REGULATION OF HEART RATE BY CARDIAC CONDUCTION |
12 |
30 |
3.361e-05 |
0.0003085 |
507 |
REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS |
44 |
218 |
3.35e-05 |
0.0003085 |
508 |
TISSUE REMODELING |
23 |
87 |
3.658e-05 |
0.0003351 |
509 |
REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY |
65 |
365 |
3.777e-05 |
0.0003453 |
510 |
NEPHRON EPITHELIUM DEVELOPMENT |
24 |
93 |
3.84e-05 |
0.0003503 |
511 |
INOSITOL PHOSPHATE MEDIATED SIGNALING |
9 |
18 |
3.932e-05 |
0.000358 |
512 |
DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION |
97 |
602 |
3.954e-05 |
0.0003594 |
513 |
CEREBRAL CORTEX DEVELOPMENT |
26 |
105 |
4.035e-05 |
0.000366 |
514 |
PEPTIDYL SERINE MODIFICATION |
33 |
148 |
4.086e-05 |
0.0003699 |
515 |
POSITIVE REGULATION OF MUSCLE HYPERTROPHY |
10 |
22 |
4.111e-05 |
0.0003707 |
516 |
POSITIVE REGULATION OF CARDIAC MUSCLE HYPERTROPHY |
10 |
22 |
4.111e-05 |
0.0003707 |
517 |
PLATELET ACTIVATION |
32 |
142 |
4.26e-05 |
0.0003834 |
518 |
REGULATION OF INTRACELLULAR PROTEIN TRANSPORT |
67 |
381 |
4.337e-05 |
0.0003885 |
519 |
ENDODERM DEVELOPMENT |
20 |
71 |
4.341e-05 |
0.0003885 |
520 |
ADHERENS JUNCTION ORGANIZATION |
20 |
71 |
4.341e-05 |
0.0003885 |
521 |
REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY |
14 |
40 |
4.427e-05 |
0.0003947 |
522 |
GLIAL CELL DIFFERENTIATION |
31 |
136 |
4.42e-05 |
0.0003947 |
523 |
REGULATION OF STEM CELL PROLIFERATION |
23 |
88 |
4.451e-05 |
0.000396 |
524 |
REGULATION OF ADHERENS JUNCTION ORGANIZATION |
16 |
50 |
4.564e-05 |
0.0004045 |
525 |
POSITIVE REGULATION OF STEM CELL DIFFERENTIATION |
16 |
50 |
4.564e-05 |
0.0004045 |
526 |
SPROUTING ANGIOGENESIS |
15 |
45 |
4.591e-05 |
0.0004061 |
527 |
POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
25 |
100 |
4.748e-05 |
0.0004192 |
528 |
CARDIAC VENTRICLE DEVELOPMENT |
26 |
106 |
4.802e-05 |
0.0004232 |
529 |
REGULATION OF VASOCONSTRICTION |
19 |
66 |
4.818e-05 |
0.0004238 |
530 |
POSITIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY |
45 |
228 |
4.858e-05 |
0.0004265 |
531 |
POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION |
35 |
162 |
4.872e-05 |
0.0004269 |
532 |
NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT |
32 |
143 |
4.927e-05 |
0.0004309 |
533 |
REGULATION OF PLATELET ACTIVATION |
12 |
31 |
4.945e-05 |
0.0004317 |
534 |
REGULATION OF ACTIN FILAMENT LENGTH |
34 |
156 |
5.148e-05 |
0.0004486 |
535 |
RESPONSE TO KETONE |
38 |
182 |
5.223e-05 |
0.0004543 |
536 |
REGULATION OF BLOOD PRESSURE |
36 |
169 |
5.24e-05 |
0.0004549 |
537 |
POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT |
30 |
131 |
5.31e-05 |
0.0004593 |
538 |
BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE |
30 |
131 |
5.31e-05 |
0.0004593 |
539 |
POST EMBRYONIC DEVELOPMENT |
23 |
89 |
5.394e-05 |
0.0004656 |
540 |
NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION |
42 |
209 |
5.551e-05 |
0.0004783 |
541 |
POSITIVE REGULATION OF CELL CELL ADHESION |
47 |
243 |
5.65e-05 |
0.0004859 |
542 |
POSITIVE REGULATION OF PROTEIN ACETYLATION |
13 |
36 |
5.68e-05 |
0.0004868 |
543 |
POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT |
17 |
56 |
5.681e-05 |
0.0004868 |
544 |
REGULATION OF CARDIAC MUSCLE CELL CONTRACTION |
11 |
27 |
5.857e-05 |
0.0005009 |
545 |
AMINO ACID IMPORT |
8 |
15 |
5.959e-05 |
0.0005088 |
546 |
NEGATIVE REGULATION OF CHEMOTAXIS |
16 |
51 |
5.987e-05 |
0.0005102 |
547 |
NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION |
14 |
41 |
6.057e-05 |
0.0005152 |
548 |
CYCLIC NUCLEOTIDE MEDIATED SIGNALING |
15 |
46 |
6.135e-05 |
0.0005209 |
549 |
REGULATION OF LYMPHOCYTE DIFFERENTIATION |
30 |
132 |
6.171e-05 |
0.000523 |
550 |
REGULATION OF NEUROTRANSMITTER LEVELS |
39 |
190 |
6.217e-05 |
0.000526 |
551 |
REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING |
10 |
23 |
6.568e-05 |
0.0005546 |
552 |
MYELOID LEUKOCYTE DIFFERENTIATION |
24 |
96 |
6.673e-05 |
0.0005615 |
553 |
REGULATION OF EMBRYONIC DEVELOPMENT |
27 |
114 |
6.672e-05 |
0.0005615 |
554 |
DIVALENT INORGANIC CATION HOMEOSTASIS |
61 |
343 |
6.712e-05 |
0.0005637 |
555 |
REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION |
26 |
108 |
6.742e-05 |
0.0005652 |
556 |
REGULATION OF ACTIN FILAMENT BASED MOVEMENT |
12 |
32 |
7.136e-05 |
0.0005972 |
557 |
RESPONSE TO ESTROGEN |
43 |
218 |
7.172e-05 |
0.0005991 |
558 |
REGULATION OF STRIATED MUSCLE CONTRACTION |
21 |
79 |
7.205e-05 |
0.0006008 |
559 |
REGULATION OF CARBOHYDRATE METABOLIC PROCESS |
36 |
172 |
7.697e-05 |
0.0006407 |
560 |
RESPONSE TO CALCIUM ION |
27 |
115 |
7.831e-05 |
0.0006507 |
561 |
REGULATION OF SYNAPTIC PLASTICITY |
31 |
140 |
7.913e-05 |
0.0006551 |
562 |
ADAPTIVE IMMUNE RESPONSE |
53 |
288 |
7.901e-05 |
0.0006551 |
563 |
REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION |
26 |
109 |
7.954e-05 |
0.0006574 |
564 |
GLAND MORPHOGENESIS |
24 |
97 |
7.968e-05 |
0.0006574 |
565 |
REGULATION OF MUSCLE ORGAN DEVELOPMENT |
25 |
103 |
8.004e-05 |
0.0006592 |
566 |
REGULATION OF DENDRITE MORPHOGENESIS |
20 |
74 |
8.25e-05 |
0.0006783 |
567 |
CARTILAGE MORPHOGENESIS |
7 |
12 |
8.367e-05 |
0.0006866 |
568 |
REGULATION OF LIPID METABOLIC PROCESS |
52 |
282 |
8.704e-05 |
0.000713 |
569 |
NEGATIVE REGULATION OF WOUND HEALING |
17 |
58 |
9.276e-05 |
0.0007585 |
570 |
POSITIVE REGULATION OF AXONOGENESIS |
19 |
69 |
9.374e-05 |
0.0007652 |
571 |
CELL GROWTH |
30 |
135 |
9.556e-05 |
0.0007787 |
572 |
REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE |
16 |
53 |
0.0001004 |
0.0008125 |
573 |
POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS |
69 |
406 |
1e-04 |
0.0008125 |
574 |
CELLULAR RESPONSE TO AMINO ACID STIMULUS |
16 |
53 |
0.0001004 |
0.0008125 |
575 |
POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY |
16 |
53 |
0.0001004 |
0.0008125 |
576 |
FOCAL ADHESION ASSEMBLY |
10 |
24 |
0.0001017 |
0.0008158 |
577 |
REGULATION OF BIOMINERAL TISSUE DEVELOPMENT |
20 |
75 |
0.0001012 |
0.0008158 |
578 |
POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY |
10 |
24 |
0.0001017 |
0.0008158 |
579 |
CELL SUBSTRATE ADHERENS JUNCTION ASSEMBLY |
10 |
24 |
0.0001017 |
0.0008158 |
580 |
CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION |
10 |
24 |
0.0001017 |
0.0008158 |
581 |
REGULATION OF PEPTIDE TRANSPORT |
48 |
256 |
0.0001052 |
0.0008426 |
582 |
REGULATION OF LIPID KINASE ACTIVITY |
15 |
48 |
0.0001063 |
0.0008485 |
583 |
POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION |
15 |
48 |
0.0001063 |
0.0008485 |
584 |
METANEPHROS DEVELOPMENT |
21 |
81 |
0.0001066 |
0.0008495 |
585 |
NEGATIVE REGULATION OF CYTOPLASMIC TRANSPORT |
27 |
117 |
0.0001071 |
0.0008516 |
586 |
NEGATIVE REGULATION OF ADHERENS JUNCTION ORGANIZATION |
8 |
16 |
0.0001079 |
0.000855 |
587 |
REGULATION OF MACROPHAGE CHEMOTAXIS |
8 |
16 |
0.0001079 |
0.000855 |
588 |
POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT |
13 |
38 |
0.0001081 |
0.0008558 |
589 |
REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS |
22 |
87 |
0.0001102 |
0.0008705 |
590 |
NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY |
9 |
20 |
0.000111 |
0.0008708 |
591 |
REGULATION OF MACROPHAGE DIFFERENTIATION |
9 |
20 |
0.000111 |
0.0008708 |
592 |
LYMPH VESSEL DEVELOPMENT |
9 |
20 |
0.000111 |
0.0008708 |
593 |
MELANOCYTE DIFFERENTIATION |
9 |
20 |
0.000111 |
0.0008708 |
594 |
POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION |
36 |
175 |
0.0001115 |
0.0008737 |
595 |
NEGATIVE REGULATION OF CATALYTIC ACTIVITY |
124 |
829 |
0.0001134 |
0.0008868 |
596 |
REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY |
19 |
70 |
0.0001157 |
0.0009036 |
597 |
LIPID LOCALIZATION |
49 |
264 |
0.0001162 |
0.0009056 |
598 |
REGULATION OF PROTEIN TARGETING |
55 |
307 |
0.0001226 |
0.0009537 |
599 |
MULTICELLULAR ORGANISM GROWTH |
20 |
76 |
0.0001235 |
0.0009577 |
600 |
EXTRACELLULAR MATRIX DISASSEMBLY |
20 |
76 |
0.0001235 |
0.0009577 |
601 |
REGULATION OF VACUOLAR TRANSPORT |
11 |
29 |
0.0001266 |
0.0009784 |
602 |
POSITIVE REGULATION OF CARTILAGE DEVELOPMENT |
11 |
29 |
0.0001266 |
0.0009784 |
603 |
REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS |
18 |
65 |
0.0001313 |
0.001013 |
604 |
REGULATION OF COAGULATION |
22 |
88 |
0.0001321 |
0.001016 |
605 |
REGULATION OF CATION CHANNEL ACTIVITY |
22 |
88 |
0.0001321 |
0.001016 |
606 |
PROTEIN DEPHOSPHORYLATION |
38 |
190 |
0.0001359 |
0.001044 |
607 |
CELLULAR HOMEOSTASIS |
104 |
676 |
0.0001374 |
0.001053 |
608 |
CARDIAC CELL DEVELOPMENT |
15 |
49 |
0.000138 |
0.001056 |
609 |
POSITIVE REGULATION OF GROWTH |
45 |
238 |
0.0001394 |
0.001065 |
610 |
NEGATIVE REGULATION OF CELL CELL ADHESION |
30 |
138 |
0.0001452 |
0.001108 |
611 |
TRABECULA MORPHOGENESIS |
13 |
39 |
0.0001462 |
0.001112 |
612 |
POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION |
13 |
39 |
0.0001462 |
0.001112 |
613 |
NEGATIVE REGULATION OF CYTOKINE PRODUCTION |
41 |
211 |
0.0001468 |
0.001114 |
614 |
STEM CELL PROLIFERATION |
17 |
60 |
0.0001473 |
0.001116 |
615 |
IMMUNE EFFECTOR PROCESS |
79 |
486 |
0.0001493 |
0.00113 |
616 |
DEVELOPMENTAL CELL GROWTH |
20 |
77 |
0.0001501 |
0.001133 |
617 |
CELLULAR EXTRAVASATION |
10 |
25 |
0.0001531 |
0.001151 |
618 |
REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY SARCOPLASMIC RETICULUM |
10 |
25 |
0.0001531 |
0.001151 |
619 |
PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING |
10 |
25 |
0.0001531 |
0.001151 |
620 |
CELLULAR CHEMICAL HOMEOSTASIS |
90 |
570 |
0.000154 |
0.001155 |
621 |
GLYCOPROTEIN METABOLIC PROCESS |
61 |
353 |
0.0001542 |
0.001155 |
622 |
ORGAN REGENERATION |
21 |
83 |
0.0001551 |
0.001161 |
623 |
SOMATIC STEM CELL POPULATION MAINTENANCE |
18 |
66 |
0.0001624 |
0.001209 |
624 |
MESODERM MORPHOGENESIS |
18 |
66 |
0.0001624 |
0.001209 |
625 |
REGULATION OF CARDIAC CONDUCTION |
18 |
66 |
0.0001624 |
0.001209 |
626 |
PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION |
7 |
13 |
0.0001643 |
0.001219 |
627 |
PERIPHERAL NERVOUS SYSTEM NEURON DEVELOPMENT |
7 |
13 |
0.0001643 |
0.001219 |
628 |
REGIONALIZATION |
55 |
311 |
0.0001733 |
0.001284 |
629 |
POSITIVE REGULATION OF ENDOCYTOSIS |
26 |
114 |
0.0001745 |
0.001291 |
630 |
LIPID TRANSLOCATION |
9 |
21 |
0.0001756 |
0.001297 |
631 |
RESPONSE TO ESTRADIOL |
31 |
146 |
0.0001787 |
0.001317 |
632 |
NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS |
11 |
30 |
0.0001804 |
0.001324 |
633 |
REGULATION OF MEMBRANE REPOLARIZATION |
11 |
30 |
0.0001804 |
0.001324 |
634 |
LAMELLIPODIUM ASSEMBLY |
11 |
30 |
0.0001804 |
0.001324 |
635 |
RENAL TUBULE DEVELOPMENT |
20 |
78 |
0.0001815 |
0.00133 |
636 |
CYCLIC NUCLEOTIDE CATABOLIC PROCESS |
8 |
17 |
0.0001844 |
0.001341 |
637 |
REGULATION OF PHOSPHOLIPID METABOLIC PROCESS |
17 |
61 |
0.0001838 |
0.001341 |
638 |
NEGATIVE REGULATION OF ANOIKIS |
8 |
17 |
0.0001844 |
0.001341 |
639 |
REGULATION OF PRI MIRNA TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
8 |
17 |
0.0001844 |
0.001341 |
640 |
NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION |
24 |
102 |
0.0001843 |
0.001341 |
641 |
POSITIVE REGULATION OF BINDING |
28 |
127 |
0.0001853 |
0.001345 |
642 |
TISSUE MIGRATION |
21 |
84 |
0.000186 |
0.001346 |
643 |
NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION |
21 |
84 |
0.000186 |
0.001346 |
644 |
ENDOTHELIAL CELL DEVELOPMENT |
14 |
45 |
0.0001891 |
0.001366 |
645 |
RESPONSE TO MONOAMINE |
12 |
35 |
0.0001935 |
0.001396 |
646 |
DEVELOPMENTAL PIGMENTATION |
13 |
40 |
0.0001953 |
0.001407 |
647 |
NEURON FATE COMMITMENT |
18 |
67 |
0.0001999 |
0.001437 |
648 |
EPITHELIAL TO MESENCHYMAL TRANSITION |
16 |
56 |
0.0002057 |
0.001472 |
649 |
REGULATION OF DENDRITIC SPINE DEVELOPMENT |
16 |
56 |
0.0002057 |
0.001472 |
650 |
CELLULAR RESPONSE TO ABIOTIC STIMULUS |
48 |
263 |
0.0002051 |
0.001472 |
651 |
CELL CYCLE ARREST |
32 |
154 |
0.0002154 |
0.001539 |
652 |
REGULATION OF CALCIUM ION IMPORT |
24 |
103 |
0.000216 |
0.001541 |
653 |
ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY |
30 |
141 |
0.0002169 |
0.001546 |
654 |
REGULATION OF IMMUNE RESPONSE |
126 |
858 |
0.0002201 |
0.001566 |
655 |
ENSHEATHMENT OF NEURONS |
22 |
91 |
0.0002226 |
0.001579 |
656 |
AXON ENSHEATHMENT |
22 |
91 |
0.0002226 |
0.001579 |
657 |
REPLACEMENT OSSIFICATION |
10 |
26 |
0.0002247 |
0.00158 |
658 |
AGING |
48 |
264 |
0.0002248 |
0.00158 |
659 |
MESODERMAL CELL DIFFERENTIATION |
10 |
26 |
0.0002247 |
0.00158 |
660 |
ENDOCHONDRAL OSSIFICATION |
10 |
26 |
0.0002247 |
0.00158 |
661 |
INACTIVATION OF MAPK ACTIVITY |
10 |
26 |
0.0002247 |
0.00158 |
662 |
POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION |
10 |
26 |
0.0002247 |
0.00158 |
663 |
NEURAL CREST CELL MIGRATION |
15 |
51 |
0.0002267 |
0.001591 |
664 |
WNT SIGNALING PATHWAY |
60 |
351 |
0.0002346 |
0.001644 |
665 |
ENDOCYTOSIS |
81 |
509 |
0.0002499 |
0.001749 |
666 |
REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION |
11 |
31 |
0.0002524 |
0.001764 |
667 |
POSITIVE REGULATION OF RESPONSE TO WOUNDING |
33 |
162 |
0.0002552 |
0.00178 |
668 |
MYELOID LEUKOCYTE ACTIVATION |
23 |
98 |
0.0002589 |
0.001803 |
669 |
NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION |
12 |
36 |
0.0002619 |
0.001811 |
670 |
REGULATION OF NUCLEOTIDE CATABOLIC PROCESS |
12 |
36 |
0.0002619 |
0.001811 |
671 |
NEGATIVE REGULATION OF BLOOD CIRCULATION |
12 |
36 |
0.0002619 |
0.001811 |
672 |
CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT |
12 |
36 |
0.0002619 |
0.001811 |
673 |
REGULATION OF ERYTHROCYTE DIFFERENTIATION |
12 |
36 |
0.0002619 |
0.001811 |
674 |
INNER EAR MORPHOGENESIS |
22 |
92 |
0.0002631 |
0.001816 |
675 |
POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS |
21 |
86 |
0.0002644 |
0.001823 |
676 |
NEGATIVE REGULATION OF MUSCLE CONTRACTION |
9 |
22 |
0.0002687 |
0.001841 |
677 |
BONE CELL DEVELOPMENT |
9 |
22 |
0.0002687 |
0.001841 |
678 |
CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS |
9 |
22 |
0.0002687 |
0.001841 |
679 |
CELLULAR RESPONSE TO INTERLEUKIN 6 |
9 |
22 |
0.0002687 |
0.001841 |
680 |
LEUKOCYTE CHEMOTAXIS |
26 |
117 |
0.000271 |
0.001855 |
681 |
REGULATION OF ORGANELLE ORGANIZATION |
165 |
1178 |
0.0002774 |
0.001895 |
682 |
CELLULAR RESPONSE TO OXYGEN LEVELS |
30 |
143 |
0.0002807 |
0.001915 |
683 |
REGULATION OF WNT SIGNALING PATHWAY |
54 |
310 |
0.0002917 |
0.001987 |
684 |
NEGATIVE REGULATION OF WNT SIGNALING PATHWAY |
38 |
197 |
0.0002933 |
0.001995 |
685 |
VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY |
7 |
14 |
0.0002979 |
0.002003 |
686 |
POSITIVE REGULATION OF VACUOLAR TRANSPORT |
7 |
14 |
0.0002979 |
0.002003 |
687 |
POSITIVE REGULATION OF FATTY ACID OXIDATION |
7 |
14 |
0.0002979 |
0.002003 |
688 |
NEGATIVE REGULATION OF OSSIFICATION |
18 |
69 |
0.0002979 |
0.002003 |
689 |
PERIPHERAL NERVOUS SYSTEM DEVELOPMENT |
18 |
69 |
0.0002979 |
0.002003 |
690 |
CAMP CATABOLIC PROCESS |
7 |
14 |
0.0002979 |
0.002003 |
691 |
RESPONSE TO ACTIVITY |
18 |
69 |
0.0002979 |
0.002003 |
692 |
SYNAPSE ASSEMBLY |
18 |
69 |
0.0002979 |
0.002003 |
693 |
RESPONSE TO PLATELET DERIVED GROWTH FACTOR |
8 |
18 |
0.0003005 |
0.002009 |
694 |
MAST CELL MEDIATED IMMUNITY |
8 |
18 |
0.0003005 |
0.002009 |
695 |
OSTEOBLAST DEVELOPMENT |
8 |
18 |
0.0003005 |
0.002009 |
696 |
REGULATION OF NUCLEOTIDE METABOLIC PROCESS |
40 |
211 |
0.0003004 |
0.002009 |
697 |
REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL |
19 |
75 |
0.0003083 |
0.002058 |
698 |
RESPONSE TO METAL ION |
57 |
333 |
0.0003198 |
0.002129 |
699 |
NEGATIVE REGULATION OF BINDING |
28 |
131 |
0.0003198 |
0.002129 |
700 |
REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION |
10 |
27 |
0.0003225 |
0.002137 |
701 |
REGULATION OF ASTROCYTE DIFFERENTIATION |
10 |
27 |
0.0003225 |
0.002137 |
702 |
CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS |
10 |
27 |
0.0003225 |
0.002137 |
703 |
EAR MORPHOGENESIS |
25 |
112 |
0.0003277 |
0.002169 |
704 |
REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING |
43 |
233 |
0.0003343 |
0.00221 |
705 |
NEGATIVE REGULATION OF BMP SIGNALING PATHWAY |
13 |
42 |
0.0003368 |
0.002223 |
706 |
BLOOD VESSEL REMODELING |
11 |
32 |
0.0003473 |
0.002286 |
707 |
ADIPOSE TISSUE DEVELOPMENT |
11 |
32 |
0.0003473 |
0.002286 |
708 |
REGULATION OF PROTEIN AUTOPHOSPHORYLATION |
12 |
37 |
0.0003497 |
0.002292 |
709 |
IMPORT INTO CELL |
12 |
37 |
0.0003497 |
0.002292 |
710 |
CAMP MEDIATED SIGNALING |
12 |
37 |
0.0003497 |
0.002292 |
711 |
NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION |
15 |
53 |
0.0003606 |
0.002357 |
712 |
MESONEPHRIC TUBULE MORPHOGENESIS |
15 |
53 |
0.0003606 |
0.002357 |
713 |
INFLAMMATORY RESPONSE |
73 |
454 |
0.0003626 |
0.002367 |
714 |
POSITIVE REGULATION OF TRANSPORTER ACTIVITY |
19 |
76 |
0.0003699 |
0.002411 |
715 |
REGULATION OF VESICLE MEDIATED TRANSPORT |
74 |
462 |
0.0003727 |
0.002422 |
716 |
NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION |
20 |
82 |
0.0003727 |
0.002422 |
717 |
REGULATION OF MUSCLE CELL DIFFERENTIATION |
31 |
152 |
0.000378 |
0.002453 |
718 |
REGULATION OF SEQUESTERING OF CALCIUM ION |
24 |
107 |
0.000396 |
0.002563 |
719 |
REGULATION OF T CELL DIFFERENTIATION |
24 |
107 |
0.000396 |
0.002563 |
720 |
NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION |
9 |
23 |
0.0003992 |
0.002572 |
721 |
DIGESTIVE TRACT MORPHOGENESIS |
14 |
48 |
0.0004002 |
0.002572 |
722 |
REGULATION OF OSTEOBLAST PROLIFERATION |
9 |
23 |
0.0003992 |
0.002572 |
723 |
POSITIVE REGULATION OF WOUND HEALING |
14 |
48 |
0.0004002 |
0.002572 |
724 |
REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT |
14 |
48 |
0.0004002 |
0.002572 |
725 |
NEGATIVE REGULATION OF CELL CYCLE |
70 |
433 |
0.0004054 |
0.002602 |
726 |
REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION |
23 |
101 |
0.0004121 |
0.002641 |
727 |
REGULATION OF SODIUM ION TRANSPORT |
19 |
77 |
0.0004419 |
0.002825 |
728 |
REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY |
19 |
77 |
0.0004419 |
0.002825 |
729 |
DEFENSE RESPONSE |
170 |
1231 |
0.0004469 |
0.002853 |
730 |
ALPHA BETA T CELL ACTIVATION |
15 |
54 |
0.0004499 |
0.002868 |
731 |
ENDOMEMBRANE SYSTEM ORGANIZATION |
74 |
465 |
0.0004521 |
0.002878 |
732 |
MUSCLE HYPERTROPHY |
10 |
28 |
0.0004532 |
0.002881 |
733 |
REGULATION OF CELL CYCLE G1 S PHASE TRANSITION |
30 |
147 |
0.0004602 |
0.00292 |
734 |
SUBSTRATE ADHESION DEPENDENT CELL SPREADING |
12 |
38 |
0.0004612 |
0.00292 |
735 |
REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY |
12 |
38 |
0.0004612 |
0.00292 |
736 |
ACTIN FILAMENT ORGANIZATION |
34 |
174 |
0.0004657 |
0.002944 |
737 |
CELLULAR RESPONSE TO FLUID SHEAR STRESS |
8 |
19 |
0.0004699 |
0.002946 |
738 |
REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION |
8 |
19 |
0.0004699 |
0.002946 |
739 |
KIDNEY VASCULATURE DEVELOPMENT |
8 |
19 |
0.0004699 |
0.002946 |
740 |
REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS |
8 |
19 |
0.0004699 |
0.002946 |
741 |
EMBRYONIC DIGESTIVE TRACT DEVELOPMENT |
11 |
33 |
0.0004704 |
0.002946 |
742 |
NEGATIVE REGULATION OF JNK CASCADE |
11 |
33 |
0.0004704 |
0.002946 |
743 |
RENAL SYSTEM VASCULATURE DEVELOPMENT |
8 |
19 |
0.0004699 |
0.002946 |
744 |
REGULATION OF CELLULAR RESPONSE TO STRESS |
103 |
691 |
0.0004747 |
0.002968 |
745 |
RENAL SYSTEM PROCESS |
23 |
102 |
0.0004784 |
0.002988 |
746 |
REGULATION OF GLUCOSE IMPORT |
16 |
60 |
0.0004861 |
0.003032 |
747 |
MEMBRANE ORGANIZATION |
129 |
899 |
0.0004877 |
0.003038 |
748 |
CALCIUM ION TRANSPORT |
41 |
223 |
0.0004911 |
0.003055 |
749 |
DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS |
40 |
216 |
0.0004922 |
0.003057 |
750 |
CELLULAR RESPONSE TO ALCOHOL |
25 |
115 |
0.0005001 |
0.003102 |
751 |
NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS |
7 |
15 |
0.0005064 |
0.003137 |
752 |
INTRACELLULAR RECEPTOR SIGNALING PATHWAY |
33 |
168 |
0.000508 |
0.003143 |
753 |
CELLULAR RESPONSE TO CYTOKINE STIMULUS |
92 |
606 |
0.0005107 |
0.003156 |
754 |
ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE |
21 |
90 |
0.0005115 |
0.003156 |
755 |
POSITIVE REGULATION OF CELL GROWTH |
30 |
148 |
0.0005185 |
0.003195 |
756 |
LIPID MODIFICATION |
39 |
210 |
0.0005422 |
0.003337 |
757 |
REGULATION OF CIRCADIAN RHYTHM |
23 |
103 |
0.0005539 |
0.003405 |
758 |
REGULATION OF TYROSINE PHOSPHORYLATION OF STAT3 PROTEIN |
13 |
44 |
0.0005574 |
0.003422 |
759 |
POSITIVE REGULATION OF CELL ACTIVATION |
53 |
311 |
0.0005658 |
0.003469 |
760 |
REGULATION OF MYELOID CELL APOPTOTIC PROCESS |
9 |
24 |
0.0005777 |
0.003519 |
761 |
REGULATION OF POSITIVE CHEMOTAXIS |
9 |
24 |
0.0005777 |
0.003519 |
762 |
REGULATION OF ANOIKIS |
9 |
24 |
0.0005777 |
0.003519 |
763 |
POSITIVE REGULATION OF CATION TRANSMEMBRANE TRANSPORT |
22 |
97 |
0.0005777 |
0.003519 |
764 |
REGULATION OF APOPTOTIC SIGNALING PATHWAY |
60 |
363 |
0.0005747 |
0.003519 |
765 |
REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT |
16 |
61 |
0.0005936 |
0.003606 |
766 |
POSITIVE REGULATION OF STEM CELL PROLIFERATION |
16 |
61 |
0.0005936 |
0.003606 |
767 |
CELLULAR RESPONSE TO STEROID HORMONE STIMULUS |
40 |
218 |
0.0005953 |
0.003611 |
768 |
REPRODUCTION |
177 |
1297 |
0.0006088 |
0.003689 |
769 |
CARDIAC SEPTUM DEVELOPMENT |
20 |
85 |
0.0006138 |
0.003714 |
770 |
CELLULAR RESPONSE TO DRUG |
17 |
67 |
0.0006151 |
0.003717 |
771 |
POSITIVE REGULATION OF HEMOPOIESIS |
32 |
163 |
0.0006186 |
0.003729 |
772 |
VASCULAR PROCESS IN CIRCULATORY SYSTEM |
32 |
163 |
0.0006186 |
0.003729 |
773 |
PIGMENT CELL DIFFERENTIATION |
10 |
29 |
0.0006252 |
0.003763 |
774 |
REGULATION OF MESENCHYMAL CELL PROLIFERATION |
11 |
34 |
0.0006279 |
0.003775 |
775 |
REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT |
14 |
50 |
0.0006324 |
0.003797 |
776 |
POSITIVE REGULATION OF PROTEIN IMPORT |
23 |
104 |
0.0006395 |
0.003835 |
777 |
PEPTIDYL AMINO ACID MODIFICATION |
121 |
841 |
0.0006512 |
0.0039 |
778 |
REGULATION OF HORMONE SECRETION |
46 |
262 |
0.0006622 |
0.003961 |
779 |
NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION |
22 |
98 |
0.00067 |
0.004002 |
780 |
EMBRYONIC HEMOPOIESIS |
8 |
20 |
0.0007091 |
0.004198 |
781 |
ALPHA BETA T CELL DIFFERENTIATION |
13 |
45 |
0.000707 |
0.004198 |
782 |
VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT |
13 |
45 |
0.000707 |
0.004198 |
783 |
NEGATIVE REGULATION OF TRANSFERASE ACTIVITY |
58 |
351 |
0.0007079 |
0.004198 |
784 |
PARTURITION |
8 |
20 |
0.0007091 |
0.004198 |
785 |
RESPONSE TO MUSCLE ACTIVITY |
8 |
20 |
0.0007091 |
0.004198 |
786 |
RESPONSE TO LEPTIN |
8 |
20 |
0.0007091 |
0.004198 |
787 |
FOREBRAIN CELL MIGRATION |
16 |
62 |
0.0007207 |
0.004261 |
788 |
RETINA DEVELOPMENT IN CAMERA TYPE EYE |
27 |
131 |
0.0007365 |
0.004349 |
789 |
REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN |
17 |
68 |
0.0007386 |
0.00435 |
790 |
REGULATION OF PHAGOCYTOSIS |
17 |
68 |
0.0007386 |
0.00435 |
791 |
MESODERM DEVELOPMENT |
25 |
118 |
0.0007472 |
0.004395 |
792 |
PLACENTA DEVELOPMENT |
28 |
138 |
0.0007697 |
0.004522 |
793 |
MYELOID LEUKOCYTE MIGRATION |
22 |
99 |
0.0007749 |
0.004537 |
794 |
POSITIVE REGULATION OF CELL MATRIX ADHESION |
12 |
40 |
0.0007752 |
0.004537 |
795 |
NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION |
12 |
40 |
0.0007752 |
0.004537 |
796 |
REGULATION OF PROTEIN COMPLEX ASSEMBLY |
61 |
375 |
0.0007874 |
0.004603 |
797 |
PHOSPHATIDYLINOSITOL METABOLIC PROCESS |
36 |
193 |
0.0007983 |
0.00466 |
798 |
EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS |
21 |
93 |
0.0008103 |
0.004724 |
799 |
REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION |
9 |
25 |
0.0008165 |
0.004743 |
800 |
CARDIAC RIGHT VENTRICLE MORPHOGENESIS |
7 |
16 |
0.0008163 |
0.004743 |
801 |
RESPONSE TO EPINEPHRINE |
7 |
16 |
0.0008163 |
0.004743 |
802 |
REGULATION OF GASTRULATION |
11 |
35 |
0.000827 |
0.004798 |
803 |
L AMINO ACID IMPORT |
6 |
12 |
0.0008298 |
0.004808 |
804 |
B CELL ACTIVATION |
27 |
132 |
0.0008322 |
0.004816 |
805 |
POSITIVE REGULATION OF CALCIUM ION TRANSPORT |
23 |
106 |
0.0008458 |
0.004857 |
806 |
SMOOTH MUSCLE CELL DIFFERENTIATION |
10 |
30 |
0.0008476 |
0.004857 |
807 |
NEURON MATURATION |
10 |
30 |
0.0008476 |
0.004857 |
808 |
NEGATIVE REGULATION OF B CELL ACTIVATION |
10 |
30 |
0.0008476 |
0.004857 |
809 |
NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY |
10 |
30 |
0.0008476 |
0.004857 |
810 |
NEGATIVE REGULATION OF CELL MATRIX ADHESION |
10 |
30 |
0.0008476 |
0.004857 |
811 |
ESTABLISHMENT OF ENDOTHELIAL BARRIER |
10 |
30 |
0.0008476 |
0.004857 |
812 |
CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS |
10 |
30 |
0.0008476 |
0.004857 |
813 |
REGULATION OF PROTEIN POLYMERIZATION |
33 |
173 |
0.000867 |
0.004944 |
814 |
REGULATION OF FIBROBLAST PROLIFERATION |
19 |
81 |
0.0008649 |
0.004944 |
815 |
REGULATION OF CELL SHAPE |
28 |
139 |
0.0008662 |
0.004944 |
816 |
REGULATION OF JUN KINASE ACTIVITY |
19 |
81 |
0.0008649 |
0.004944 |
817 |
NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS |
16 |
63 |
0.0008704 |
0.004957 |
818 |
POSITIVE REGULATION OF AUTOPHAGY |
18 |
75 |
0.0008798 |
0.005004 |
819 |
REGULATION OF INTERLEUKIN 10 PRODUCTION |
13 |
46 |
0.0008891 |
0.005045 |
820 |
POSITIVE REGULATION OF PHAGOCYTOSIS |
13 |
46 |
0.0008891 |
0.005045 |
821 |
NEGATIVE REGULATION OF INFLAMMATORY RESPONSE |
22 |
100 |
0.0008936 |
0.005064 |
822 |
POSITIVE REGULATION OF CYTOKINE PRODUCTION |
60 |
370 |
0.0009353 |
0.005294 |
823 |
REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS |
21 |
94 |
0.0009387 |
0.005307 |
824 |
SINGLE ORGANISM CELLULAR LOCALIZATION |
127 |
898 |
0.0009471 |
0.005348 |
825 |
REGULATION OF PEPTIDE SECRETION |
38 |
209 |
0.0009597 |
0.005413 |
826 |
CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS |
35 |
188 |
0.0009697 |
0.005462 |
827 |
REGULATION OF MEMBRANE DEPOLARIZATION |
12 |
41 |
0.0009892 |
0.005549 |
828 |
NEGATIVE REGULATION OF STRESS ACTIVATED MAPK CASCADE |
12 |
41 |
0.0009892 |
0.005549 |
829 |
NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
12 |
41 |
0.0009892 |
0.005549 |
830 |
REGULATION OF IMMUNE EFFECTOR PROCESS |
67 |
424 |
0.0009898 |
0.005549 |
831 |
REGULATION OF ERK1 AND ERK2 CASCADE |
42 |
238 |
0.0009978 |
0.005587 |
832 |
KIDNEY MORPHOGENESIS |
19 |
82 |
0.001013 |
0.005667 |
833 |
REGULATION OF G PROTEIN COUPLED RECEPTOR PROTEIN SIGNALING PATHWAY |
26 |
127 |
0.001015 |
0.005667 |
834 |
PHOSPHOLIPID TRANSPORT |
15 |
58 |
0.00102 |
0.005693 |
835 |
MAST CELL ACTIVATION |
8 |
21 |
0.001037 |
0.005761 |
836 |
SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT |
8 |
21 |
0.001037 |
0.005761 |
837 |
REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS |
8 |
21 |
0.001037 |
0.005761 |
838 |
SIALYLATION |
8 |
21 |
0.001037 |
0.005761 |
839 |
REGULATION OF NEUROTRANSMITTER TRANSPORT |
16 |
64 |
0.001046 |
0.005792 |
840 |
REGULATION OF PROTEIN ACETYLATION |
16 |
64 |
0.001046 |
0.005792 |
841 |
GLYCEROPHOSPHOLIPID METABOLIC PROCESS |
50 |
297 |
0.001051 |
0.005813 |
842 |
REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION |
37 |
203 |
0.00106 |
0.005859 |
843 |
HOMEOSTASIS OF NUMBER OF CELLS |
33 |
175 |
0.001064 |
0.005871 |
844 |
LAMELLIPODIUM ORGANIZATION |
11 |
36 |
0.001076 |
0.005916 |
845 |
SEMAPHORIN PLEXIN SIGNALING PATHWAY |
11 |
36 |
0.001076 |
0.005916 |
846 |
T CELL SELECTION |
11 |
36 |
0.001076 |
0.005916 |
847 |
NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT |
21 |
95 |
0.001084 |
0.005956 |
848 |
ENTRAINMENT OF CIRCADIAN CLOCK |
9 |
26 |
0.00113 |
0.006184 |
849 |
RESPONSE TO INTERLEUKIN 6 |
9 |
26 |
0.00113 |
0.006184 |
850 |
HEART GROWTH |
9 |
26 |
0.00113 |
0.006184 |
851 |
REGULATION OF SYNAPTIC VESICLE TRANSPORT |
10 |
31 |
0.001131 |
0.006184 |
852 |
POSITIVE REGULATION OF FIBROBLAST PROLIFERATION |
14 |
53 |
0.001188 |
0.006475 |
853 |
REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS |
14 |
53 |
0.001188 |
0.006475 |
854 |
POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
27 |
135 |
0.001187 |
0.006475 |
855 |
CELL FATE SPECIFICATION |
17 |
71 |
0.001244 |
0.006768 |
856 |
CELLULAR RESPONSE TO RETINOIC ACID |
16 |
65 |
0.00125 |
0.006772 |
857 |
REGULATION OF CELLULAR CARBOHYDRATE CATABOLIC PROCESS |
12 |
42 |
0.00125 |
0.006772 |
858 |
POSITIVE REGULATION OF GLUCOSE TRANSPORT |
12 |
42 |
0.00125 |
0.006772 |
859 |
REGULATION OF CARBOHYDRATE CATABOLIC PROCESS |
12 |
42 |
0.00125 |
0.006772 |
860 |
REGULATION OF ENERGY HOMEOSTASIS |
7 |
17 |
0.001259 |
0.006778 |
861 |
REGULATION OF PLATELET AGGREGATION |
7 |
17 |
0.001259 |
0.006778 |
862 |
REGULATION OF CALCINEURIN NFAT SIGNALING CASCADE |
7 |
17 |
0.001259 |
0.006778 |
863 |
POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS |
7 |
17 |
0.001259 |
0.006778 |
864 |
DEFINITIVE HEMOPOIESIS |
7 |
17 |
0.001259 |
0.006778 |
865 |
RESPONSE TO HYDROGEN PEROXIDE |
23 |
109 |
0.001262 |
0.00679 |
866 |
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS |
26 |
129 |
0.001289 |
0.006924 |
867 |
EYE MORPHOGENESIS |
27 |
136 |
0.001331 |
0.007143 |
868 |
NEGATIVE REGULATION OF COAGULATION |
13 |
48 |
0.001372 |
0.007346 |
869 |
COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT |
13 |
48 |
0.001372 |
0.007346 |
870 |
POSITIVE REGULATION OF CATION CHANNEL ACTIVITY |
11 |
37 |
0.001383 |
0.007361 |
871 |
REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE |
19 |
84 |
0.001376 |
0.007361 |
872 |
REGULATION OF MEMBRANE LIPID DISTRIBUTION |
11 |
37 |
0.001383 |
0.007361 |
873 |
POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT3 PROTEIN |
11 |
37 |
0.001383 |
0.007361 |
874 |
AXON EXTENSION |
11 |
37 |
0.001383 |
0.007361 |
875 |
RELAXATION OF CARDIAC MUSCLE |
6 |
13 |
0.0014 |
0.007412 |
876 |
PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION |
6 |
13 |
0.0014 |
0.007412 |
877 |
NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION |
6 |
13 |
0.0014 |
0.007412 |
878 |
NEGATIVE REGULATION OF CARDIAC MUSCLE CELL APOPTOTIC PROCESS |
6 |
13 |
0.0014 |
0.007412 |
879 |
ENDOCRINE SYSTEM DEVELOPMENT |
25 |
123 |
0.001397 |
0.007412 |
880 |
REGULATION OF ENDOCYTOSIS |
36 |
199 |
0.001409 |
0.007451 |
881 |
POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY |
32 |
171 |
0.00143 |
0.007553 |
882 |
CELLULAR RESPONSE TO STRESS |
206 |
1565 |
0.001439 |
0.007593 |
883 |
ACTIVIN RECEPTOR SIGNALING PATHWAY |
8 |
22 |
0.001477 |
0.007782 |
884 |
ENDOCARDIAL CUSHION DEVELOPMENT |
10 |
32 |
0.001487 |
0.007819 |
885 |
METANEPHRIC NEPHRON DEVELOPMENT |
10 |
32 |
0.001487 |
0.007819 |
886 |
REGULATION OF RECEPTOR ACTIVITY |
24 |
117 |
0.00151 |
0.007922 |
887 |
CELLULAR RESPONSE TO STARVATION |
24 |
117 |
0.00151 |
0.007922 |
888 |
NEGATIVE REGULATION OF DEFENSE RESPONSE |
28 |
144 |
0.001523 |
0.00798 |
889 |
NEGATIVE REGULATION OF AXON GUIDANCE |
9 |
27 |
0.001533 |
0.007981 |
890 |
REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
9 |
27 |
0.001533 |
0.007981 |
891 |
REGULATION OF CATENIN IMPORT INTO NUCLEUS |
9 |
27 |
0.001533 |
0.007981 |
892 |
POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION |
9 |
27 |
0.001533 |
0.007981 |
893 |
SUBSTRATE DEPENDENT CELL MIGRATION |
9 |
27 |
0.001533 |
0.007981 |
894 |
POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT |
9 |
27 |
0.001533 |
0.007981 |
895 |
CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES |
22 |
104 |
0.001539 |
0.007999 |
896 |
REGULATION OF CANONICAL WNT SIGNALING PATHWAY |
41 |
236 |
0.001548 |
0.00804 |
897 |
REGULATION OF PROTEIN CATABOLIC PROCESS |
62 |
393 |
0.001556 |
0.00807 |
898 |
REGULATION OF MUSCLE CELL APOPTOTIC PROCESS |
12 |
43 |
0.001566 |
0.008112 |
899 |
PROTEIN STABILIZATION |
26 |
131 |
0.001624 |
0.008407 |
900 |
SEX DIFFERENTIATION |
45 |
266 |
0.001643 |
0.008494 |
901 |
AUTOPHAGY |
62 |
394 |
0.001656 |
0.008551 |
902 |
REGULATION OF LEUKOCYTE APOPTOTIC PROCESS |
18 |
79 |
0.001666 |
0.008592 |
903 |
CELLULAR MACROMOLECULE LOCALIZATION |
166 |
1234 |
0.001673 |
0.008623 |
904 |
REGULATION OF NUCLEOSIDE METABOLIC PROCESS |
13 |
49 |
0.001685 |
0.008663 |
905 |
REGULATION OF ATP METABOLIC PROCESS |
13 |
49 |
0.001685 |
0.008663 |
906 |
REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION |
24 |
118 |
0.001705 |
0.008756 |
907 |
ANTERIOR POSTERIOR PATTERN SPECIFICATION |
35 |
194 |
0.001708 |
0.008761 |
908 |
POSITIVE REGULATION OF STAT CASCADE |
17 |
73 |
0.001722 |
0.008786 |
909 |
REGULATION OF CHROMATIN ORGANIZATION |
29 |
152 |
0.001719 |
0.008786 |
910 |
CELLULAR RESPONSE TO KETONE |
17 |
73 |
0.001722 |
0.008786 |
911 |
POSITIVE REGULATION OF JAK STAT CASCADE |
17 |
73 |
0.001722 |
0.008786 |
912 |
REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION |
17 |
73 |
0.001722 |
0.008786 |
913 |
CALCIUM ION TRANSMEMBRANE TRANSPORT |
30 |
159 |
0.001733 |
0.008831 |
914 |
ODONTOGENESIS |
22 |
105 |
0.001751 |
0.008915 |
915 |
POSITIVE REGULATION OF POTASSIUM ION TRANSPORT |
11 |
38 |
0.001758 |
0.00893 |
916 |
REGULATION OF RENAL SYSTEM PROCESS |
11 |
38 |
0.001758 |
0.00893 |
917 |
ION TRANSPORT |
169 |
1262 |
0.001851 |
0.009394 |
918 |
CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE |
27 |
139 |
0.001858 |
0.009417 |
919 |
RESPONSE TO CAFFEINE |
7 |
18 |
0.001868 |
0.00946 |
920 |
STRIATED MUSCLE CONTRACTION |
21 |
99 |
0.001876 |
0.009489 |
921 |
DIVALENT INORGANIC CATION TRANSPORT |
45 |
268 |
0.001913 |
0.009664 |
922 |
PROTEIN LOCALIZATION TO GOLGI APPARATUS |
10 |
33 |
0.001929 |
0.009736 |
923 |
POLYSACCHARIDE METABOLIC PROCESS |
18 |
80 |
0.001936 |
0.009747 |
924 |
ADULT LOCOMOTORY BEHAVIOR |
18 |
80 |
0.001936 |
0.009747 |
925 |
MYELOID CELL DEVELOPMENT |
12 |
44 |
0.001944 |
0.009777 |
926 |
ESTABLISHMENT OF PROTEIN LOCALIZATION |
188 |
1423 |
0.001953 |
0.009814 |
927 |
SPINAL CORD DEVELOPMENT |
22 |
106 |
0.001988 |
0.00997 |
928 |
REGULATION OF GLUCOSE METABOLIC PROCESS |
22 |
106 |
0.001988 |
0.00997 |